COVID-19 Evidence Reviews
as of 6/11/21
menu
 
 

 
= living review
= draft/preprint   |  
= meets mimimum quality standards   |  

A review with this mark was peer-reviewed, described systematic search and study selection, and included critical appraisal of primary studies.
latest update
date
report
select
6/11/21
Harrison SL, Buckley BJR, Rivera-Caravaca JM, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To consolidate evidence to determine (i) the association between cardiovascular risk factors and health outcomes with coronavirus 2019 (COVID-19); and (ii) the impact of COVID-19 on cardiovascular health.
6/11/21
Flumignan RL, Tinôco JDS, Pascoal PI, et al. | Br J Surg
Aim: To assess the effects of prophylactic anticoagulants for people hospitalized with COVID-19.
6/11/21
Akbar M, Pranata R, Wibowo A, et al | Eur Rev Med Pharmacol Sci
Aim: To evaluate the association between the prealbumin and severity and mortality in COVID-19.
RECENTLY UPDATED
6/10/21
SeyedAlinaghi S, Mirzapour P, Dadras O, et al. | Eur J Med Res
Aim: To characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality.
6/10/21
Lewis A, Jain R, Frontera J, | J Neuroimaging
Aim: To evaluate cerebrospinal fluid (CSF) results from patients with coronavirus disease 2019 (COVID-19) who had neurological symptoms and had an MRI that showed (1) central nervous system (CNS) hyperintense lesions not attributed to ischemia and/or (2) leptomeningeal enhancement. 
6/10/21
Hughes MC, Liu Y, Baumbach A | Gerontol Geriatr Med
Aim: To examine the current literature on the impact of COVID-19 on the health and well-being of informal caregivers for people with dementia. 
RECENTLY UPDATED
6/10/21
Nakhlband A, Fakhari A, Azizi H | J Med Virol
Aim: To investigate the efficiency of interferon-alpha against COVID-19.
6/10/21
Al Mamun F, Hosen I, Misti JM, et al. | Psychol Res Behav Manag
Aim: To review the evidence on the prevalence and associated risk factors of Bangladeshi students’ mental health sufferings (ie, depression, anxiety, and stress).
6/10/21
Guimarães D, Pissarra R, Reis-Melo A, et al. | Int J Clin Pract
Aim: To analyze current literature and reported cases of MISC, concerning its clinical spectrum, complications associated, therapeutic strategies and distinguishing features of other clinical syndromes.
6/10/21
Zein AFMZ, Sulistiyana CS, Raffaello WM, et al. | Postgrad Med J
Aim: To evaluate the effect of sofosbuvir/daclatasvir (SOF/DCV) on mortality, the need for intensive care unit (ICU) admission or invasive mechanical ventilation (IMV) and clinical recovery in patients with COVID-19.
RECENTLY UPDATED
6/9/21
Asiimwe IG, Pushpakom S, Turner R, et al | Br J Clin Pharmacol
Aim: To continually evaluate the rapidly evolving evidence base on the role of cardiovascular drugs in COVID-19 clinical outcomes (susceptibility to infection, hospitalization, hospitalization length, disease severity, and all-cause mortality).
RECENTLY UPDATED
6/9/21
Rodríguez PG, Agapito BP, Rodríguez MSA, et al. | An Pediatr
Aim: To summarize a critical appraisal document of the available evidence on COVID-19, developed with a clinical practice guide format following GRADE methodology.
6/9/21
Abbas M, Zhu NJ, Mookerjee S, et al. | J Hosp Infect
Aim: To explore and describe the current literature in HOCI surveillance.
6/9/21
Amani B, Khanijahani A, Amani B | Sci Rep
Aim: To examine the efficacy and safety of HCQ in addition to standard of care (SOC) in COVID-19.
RECENTLY UPDATED
6/9/21
Liu DT, Philips KM, Speth MM, et al. | Otolaryngol Head Neck Surg
Aim: To summarize the current state of knowledge on portable high-efficiency particulate air (HEPA) purifiers' effectiveness in eliminating airborne SARS-CoV-2 from indoor environments.
6/9/21
Matli K, Farah R, Maalouf M, et al. | Open Heart
Aim: To highlight the role of thrombosis in COVID-19 and provide new insights on the use of antithrombotic therapy in its management. 
RECENTLY UPDATED
6/9/21
Moghadasi AN, Mirmosayyeb O, Barzegar M, et al. | Neurol Sci
Aim: To estimate the pooled prevalence of COVID-19 in patients with MS.
6/8/21
Nikoloski Z, Alqunaibet AM, Alfawaz RA, et al. | BMC Public Health
Aim: To systematize the available evidence on the link between non-communicable diseases and Covid-19.
6/8/21
Yang J, D'souza R, Kharrat A, et al. | Acta Obstet Gynecol Scand
Aim: To conduct a living systematic review and meta-analyses of studies reporting pregnancy and neonatal outcomes by comparing the pandemic and pre-pandemic periods.
RECENTLY UPDATED
6/8/21
Kurnianto A, Tugasworo D, Andhitara Y, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To evaluate and summarize the scientific literature systematically to explore MT for AIS in the COVID-19 pandemic.
6/8/21
Mohan N, Fayyaz MA, Del Rio C, et al. | Egypt J Neurol Psychiatr Neurosurg
Aim: To evaluate and correlate the neuro-radiological and neurological manifestations in patients diagnosed with SARS-CoV2.To identify neuro-invasive pathways of COVID infection.
6/8/21
Sarkar S, Kannan S, Khanna P, et al. | Rev Med Virol
Aim: To explore the utility of RDW in the prognosis of COVID-19 patients.
RECENTLY UPDATED
6/8/21
Zugaj M, van Ditzhuijzen NS, Golebski K, et al. | Rhinology
Aim: To review the effects of the 7 known human coronaviruses on olfaction to determine if SARS-CoV-2 distinctly affects the olfactory system.
6/8/21
Wu KS, Lin PC, Chen YS, et al. | Ann Med
Aim: To investigate the association between statins and COVID-19 outcomes and, if possible, identify the subgroup population that benefits most from statin use.
6/8/21
Liang SB, Fang M, Liang CH, et al. | Complement Ther Med
Aim: To evaluate the therapeutic effects and safety of oral CPM for COVID-19.
6/7/21
Singh H, Maurya RK, Sharma P, et al. | Int Orthod
Aim: To provide an insight into the prevailing and emerging evidence informing potential risks related to splatter and AGPs, and risk mitigation strategies employed for reducing the potential risk of SARS-CoV-2 transmission from dental bioaerosols.
6/7/21
Liu X, Wang H, Shi S, et al. | Postgrad Med J
Aim: To evaluate the association between IL-6 and severe disease and mortality in COVID-19 disease.
RECENTLY UPDATED
6/7/21
Guerrero JI, Barragan LA, Martinez JD, et al. | BMC Infect Dis
Aim: To describe the features of the central and peripheral nervous system involvement by COVID-19 in terms of pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings.
RECENTLY UPDATED
6/7/21
Nascimento I, O Mathuna DP, von Groote TC, et al. | BMC Infect Med
Aim: To collate and summarize all published systematic reviews on the coronavirus disease (COVID-19).
RECENTLY UPDATED
6/7/21
Ruta F, Dal Mas F, Biancuzzi H, et al. | Prof Inferm
Aim: To analyze the literature relating to the impact on the mental health of nurses engaged in the management and care of Covid-19 patients.
6/7/21
Messina A, Sanfilippo F, Milani A, et al. | J Crit Care
Aim: To summarise the current knowledge regarding cardiac dysfunction in COVID-19 as assessed by echocardiography, both in ICU and non-ICU subjects.
RECENTLY UPDATED
6/7/21
Sterina E, Hermida AP, Gerberi DJ, et al. | Clin Gerontol
Aim: To examine post-traumatic stress, depression, anxiety, and well-being in older adults under quarantine.
6/7/21
Alkatout I, Biebl M, Momenimovahed Z, et al. | Front Oncol
Aim: To investigate the impact of COVID-19 on cancer screening.
6/7/21
Zuin M, Rigatelli G, Bilato C, et al. | Acta Cardiol
Aim: To evaluate the pooled incidence of acute HF as a cardiac complication of COVID-19 disease and to estimate the related mortality risk in these patients.
6/7/21
Seidu S, Kunutsor SK, Cos X, et al. | Prim Care Diabetes
Aim: To assess the indirect impact of the COVID-19 pandemic on hospitalisations for cardiovascular diseases and their management.
RECENTLY UPDATED
6/7/21
Siracusa L, Cascio A, Giordano S, et al. | Ital J Pediatr
Aim: To describe clinical characteristics, laboratory tests, radiological data and outcome of pediatric cases with SARS-CoV-2 infection complicated by neurological involvement.
6/7/21
Rogers JP, Watson CJ, Badenoch J, et al. | J Neurol Neurosurg Psychiatry
Aim: To describe the characteristics of the early literature and estimate point prevalences for neurological and neuropsychiatric manifestations.
RECENTLY UPDATED
6/7/21
Salah G, Ahmed A, Hassanain O, et al. | Nutr Cancer
Aim: To understand the role of nutrition in cancer patients during Corvid 19 era.
6/7/21
Subali AD, Wiyono L | Pathog Glob Health
Aim: To review the evidence on RT-LAMP application for rapid identification of SARS-CoV-2 infection compared to the RT-PCR assay.
6/7/21
Ao G, Wang Y, Qi X, et al. | Transplant Rev
Aim: To investigate the association between severe or fatal COVID-19 and SOT.
RECENTLY UPDATED
6/7/21
Atieh MA, Guirguis M, Alsabeeha NHM, et al. | Oral Dis
Aim: To systematically evaluate the current literature on the use of saliva test for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and carry out a meta-analysis to determine its diagnostic accuracy.
6/7/21
Chong WH, Saha BK, Hu K, et al. | Heart Lung
Aim: To describe the incidence, clinical characteristics, and outcomes of COVID-19-related pneumothorax.
6/7/21
Elsayed HH, Hassaballa AS, Ahmed TA, et al. | PLoS One
Aim: To review the evidence on IMV for COVID-associated ARDS to study its outcome among different countries.
RECENTLY UPDATED
6/7/21
Mai V, Tan BK, Mainbourg S, et al. | Vascul Pharmacol
Aim: To compare the rate of VTE between COVID-19 and non-COVID-19 cohorts with similar disease severity.
6/3/21
 | Health Information and Quality Authority
Aim: To review the international policies and guidelines relating to healthcare personnel who do not avail of COVID-19 vaccination.
6/2/21
Wilt T, Kaka AS, MacDonald R, et al. | VA Evidence Synthesis Program
Aim: To assess the clinical effectiveness and harms of remdesivir in hospitalized adults with COVID-19.
RECENTLY UPDATED
VA ESP
6/2/21
Patnaik N, Bhatia V, Mishra KG, et al. | J Family Med Prim Care
Aim: To analyse symptoms of pregnant women affected with COVID-19.
6/1/21
Hempel S, Burke RV, Hochman M, et al. | J Clin Epidemiol
Aim: To review evidence-based approaches for evaluation of strategies for policymakers.
5/21/21
O'Leary N, Kingston L, Griffin A, et al. | Scand J Public Health
Aim: To document the healthcare policies developed during the initial wave of widespread COVID-19 transmission in Ireland. 
5/20/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on COVID-19 vaccination before elective surgery, including any recommendations regarding the timing of vaccination.
5/20/21
Hampson G, Stone M, Lindsay JR, et al. | Calcif Tissue Int
Aim: To provide information on how the COVID-19 pandemic has impacted the diagnosis and management of osteoporosis.
5/20/21
Saulle R, Minozzi S, Amato L, et al. | Recenti Prog Med
Aim: To summarize the most relevant data from a literature systematic review on the impact on youths' physical health of the 2020 school closure and social distances measures implemented in response to COVID-19 pandemic.
5/19/21
Campbell H, Wood AC | Curr Nutr Rep
Aim: To examine the evidence that the dietary quality of children changed between the period preceding the COVID-19 pandemic and the first year during the pandemic.
5/17/21
 | CADTH
Aim: To review the evidence on the availability, accuracy, safety, cost, and other considerations for using self-administered screening tests at home for severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.
5/17/21
Gebreheat G, Teame H | J Multidiscip Healthc
Aim: To identify the main ethical challenges faced by nurses during COVID-19 pandemic.
5/17/21
Lei H, Yang Y, Zhou W, et al. | Lung Cancer
Aim: To provide precise estimates of the mortality rate of COVID-19 patients with lung cancer and other tumors.
UPDATED
5/17/21
El-Menyar A, Mekkodathil A, Asim M, et al. | Sci Prog
Aim: To explore the standards for research conduction, publications and retraction of articles related to COVID-19 pharmacotherapy research during the pandemic.
5/14/21
Antwi HA, Zhou L, Xu X, et al. | Healthcare
Aim: To examine the extent to which companies are able to balance their business interest with social interest through health-related CSR and how knowledge of them can help explain the potential impact of COVID-19.
5/12/21
Lin Z, Chen J, Han S | Expert Rev Anticancer Ther
Aim: To assess whether anti-cancer therapies such as surgery, chemotherapy, immunotherapy, and targeted therapy will increase the severity and mortality of cancer patients with COVID-19.
5/7/21
Rosenberger KJ, Xu C, Lin L | J Eval Clin Pract
Aim: To methodologically assess the current systematic reviews and meta-analyses on COVID-19.
5/6/21
 | Pan American Health Organization
Aim: To review the evidence on the therapeutic options for COVID-19.
5/6/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the role of daycares and schools in the transmission of COVID-19.
UPDATED
5/3/21
Peixoto AO, Costa RM, Uzun R, et al. | Pulmonology
Aim: To review the evidence on the use of lung ultrasound in COVID-19.
5/3/21
Pb S, Mittal S, Madan K, et al. | Monaldi Arch Chest Dis
Aim:  To evaluate the available evidence and performed meta-analysis of the effect of awake PP in non-intubated patients on improvement in oxygenation and reducing the need for intubation.
5/3/21
Siegel A, Zuo Y, Moghaddamcharkari N, et al. | Curr Opin Psychiatry
Aim: To synthesize the extant literature reporting on barriers of telemental health (TMH) during the COVID-19 pandemic and how facilities have worked to overcome these barriers, to inform best practices for TMH delivery.
5/3/21
Neira C, Godinho R, Rincon F, et al. | Nutrients
Aim: To evaluate the current evidence about the impact that preventive measures of physical contact restriction causes in healthy nutrition.
UPDATED
5/3/21
Gianfredi V, Mauer NS, Gentile L, et al. | Int J Environ Res Public Health
Aim: To evaluate the available scientific evidence on the risks of recreational skiing for the evolution of the COVID-19 pandemic.
5/3/21
Corrao S, Mallaci Bocchio R, Lo Monaco M, et al. | Nutrients
Aim: To analyze the current knowledge from systematic reviews of the relationship between nutraceutical supports and the reduction in inflammatory response to formulate clinical recommendations and highlight directions for future research during the COVID-19 pandemic. 
5/3/21
Nobari H, Fashi M, Eskandari A, et al. | Int J Environ Res Public Health
Aim: To assess and provide an up-to-date analysis of the impact of coronavirus disease 2019 (COVID-19) pandemic on the health-related quality of life (HRQoL) of children and adolescents.
5/3/21
Regmi K, Lwin CM | Int J Environ Res Public Health
Aim: To review the factors associated with the implementation of NPIs (social distancing, social isolation and quarantine) for reducing COVID-19.
5/3/21
La Verde M, Riemma G, Torella M, et al. | Int J Gynaecol Obstet
Aim: To evaluate the characteristics of pregnant women deceased due to COVID-19.
UPDATED
5/3/21
Putri C, Hariyanto TI, Hananto JE, et al. | Parkinsonism Relat Disord
Aim: To analyze the relationship between PD and in-hospital outcomes of COVID-19.
5/3/21
Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M, et al. | J Cardiovasc Med
Aim: To summarize the clinical features, diagnostic methods, treatment, and outcomes of coronavirus disease 2019 (COVID-19) patients with pericarditis.
5/3/21
Ponnapa Reddy M, Subramaniam A, et al. | Crit Care Med
Aim: To evaluate the impact of prone positioning on oxygenation and clinical outcomes.
5/3/21
Mojahed A, Brym S, Hense H, et al. | Front Psychiatry
Aim: To review the evidence on the context of social and geographical isolation and their associations with intimate partner violence.
5/3/21
Dramé M, Cofais C, Hentzien M, et al. | Nutrients
Aim: To identify and synthesize the best available evidence on the association between vitamin D level and risk of COVID-19, adverse outcomes and possible benefits of supplementation aged 60 years or over.
UPDATED
5/3/21
Magnavita N, Chirico F, Garbarino S, et al. | Int J Environ Res Public Health
Aim: To summarize and combine relevant data from existing systematic reviews and meta-analyses in order to evaluate the association of coronaviruses (SARS, MERS, SARS-CoV-2) with BOS in HCWs.
5/3/21
Hasan T, Beardsley J, Marais BJ, et al. | Vaccines
Aim: To assess the publicly-available policies and implementation strategies used for COVID-19 mass vaccination.
5/3/21
Bareille M, Hardy M, Douxfils J, et al. | J Clin Med
Aim: To assess the potential usefulness of viscoelastometric testing (VET) to predict thrombotic events in COVID-19 patients.
4/30/21
 | NSW Health COVID-19 Critical Intelligence Unit
4/30/21
 | NSW Health COVID-19 Critical Intelligence Unit
4/30/21
Crawshaw J, Konnyu K, Castillo G, et al. | The Ottawa Hospital Research Institute
Aim: To review the evidence on how behavioural science can help inform messaging to and broader supports for the general public to encourage vaccination for COVID-19.
4/30/21
Blum P, Putzer D, Liebensteiner MC, et al. | In Vivo
Aim: To provide a systematic review of the published literature on the impact by the Covid-19 pandemic on orthopaedic and traumatological care by focusing on the number of clinical visits, surgeries and reasons for consultation.
4/30/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on what is known about reasons for vaccine confidence and uptake in populations experiencing inequities.
4/29/21
Córdova LDS, Vega APM, Luján-Carpio E, et al. | Dement Neuropsychol
Aim: To describe the characteristics of COVID-19 patients, both over and under 80 years old, by conducting a systematic review of the literature describing case reports, and to summarize and critically assess these characteristics.
4/29/21
Schlesinger S, Neuenschwander M, Lang A, et al. | Diabetologia
Aim: To identify high-risk phenotypes of diabetes associated with COVID-19 severity and death.
4/29/21
Rogers JP, Chesney E, Oliver D, et al. | Epidemiol Psychiatr Sci
Aim: To establish whether infectious epidemics are associated with any changes in the incidence of suicide or the period prevalence of self-harm, or thoughts of suicide or self-harm, with a secondary objective of establishing the frequency of these outcomes.
4/28/21
Ren X, Ren X, Lou J, et al. | EClinicalMedicine
Aim: To comprehensively analyze the COVID-19 patients with RP RT-PCR result after discharged through the inclusion of extensive relevant studies; focus on the clinical characteristics, the possible causes and risk factors.
4/28/21
Elavarasi A, Sahoo RK, Seth T, et al. | Natl Med J India
Aim: To review the evidence on anti-IL-6 therapies in the treatment of COVID-19.
4/28/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on COVID-19 vaccination for immunocompromised patients including risks and adverse events, efficacy and advice from professional colleges.
4/28/21
Bartoszko JJ, Siemieniuk RAC, Kum E, et al. | BMJ
Aim: To determine and compare the effects of drug prophylaxis on severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (covid-19).
UPDATED
4/27/21
Mackey K, Kansagara D, Vela K | Ann Intern Med
Aim: To synthesize evidence on the role of ACE inhibitor and ARB use on patient outcomes in COVID-19 as well as evidence on the benefits and harms of initiating these medications to treat patients with COVID-19.
UPDATED
WHO COLLABORATIVE
VA ESP
4/19/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy of rapid, point-of-care tests for COVID-19.
4/15/21
De Armond M, Feliciano S, Hirabayashi E, et al.  | JBI Evid Synth
4/15/21
Chew NW, Ow ZGW, Teo VXY, et al. | Can J Cardiol
Aim: To examine the global impact of COVID-19 pandemic on incidence of STEMI admissions, and relationship between the pandemic and door-to-balloon time (D2B), all-cause mortality and other secondary STEMI outcomes.
4/14/21
Sohrabizadeh S, Yousefian S, Bahramzadeh A, et al. | BMC Public Health
Aim: To identify the literature focused on health system response to coincidence of COVID-19 and disasters as well as describing their finding, implications and lessons-learned.
4/13/21
 | NSW Health COVID-19 Critical Intelligence Unit
4/12/21
Meza N, Perez-Bracchiglione J, Perez I, et al. | Medwave
Aim: To provide a timely, rigorous, and continuously updated summary of the evidence available on the role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in the treatment of patients with COVID-19.
UPDATED
4/12/21
Nguyen T, Buxton JA | Int J Drug Policy
Aim: To review the evidence on the unintended pathways between COVID-19 public health responses and increasing illicit drug overdoses.
4/8/21
Medina C, Chavira J, Aburto T, et al. | Salud Publica de Mexico
Aim: To describe the available evidence on the transmission of Covid-19 or similar acute respiratory infections in open, public spaces.
4/5/21
Li YC, Lai T, Lin S, et al. | Ther Adv Chronic Dis
Aim: To evaluate the influence of pre-existing CKD on risks of all-cause mortality, hospitalization, and critically ill condition among patients with COVID-19 infection.
UPDATED
4/2/21
Zhao M, Zhao C, Tu S, et al. | J Integr Med
Aim: To assess the methodological quality and variability in implementation of randomized controlled trials (RCTs) for treating COVID-19, and to analyze the support that should be provided to improve data collected during an urgent pandemic situation.
4/1/21
Hilal N, Shaya R, Hamadeh R, et al. | Knowledge to Policy (K2P) Center
Aim: To review the evidence on the integration of COVID-19 vaccination into the services delivered by the National Primary Health Care network in Lebanon.
3/31/21
 | Health Information and Quality Authority
Aim: To explore potential populations for consideration in vaccine allocation group nine based on national and international evidence for the risk of infection, and risk of severe disease, with COVID-19.
3/31/21
Crawshaw J, Castillo G, Grimshaw J, et al. | The Ottawa Hospital Research Institute
Aim: To review the evidence on how behavioural science can help inform messaging to and broader supports for healthcare workers to encourage vaccination for COVID-19?
3/30/21
Chou R, Dana T, Buckley D, et al. | Ann Intern Med
Aim: To examine the burden of SARS-CoV-2, SARS-CoV-1, and Middle Eastern respiratory syndrome (MERS)-CoV on HCWs and risk factors for infection, using rapid and living review methods.
UPDATED
WHO COLLABORATIVE
3/29/21
Tuite AR, Fisman DN, Odutayo A, et al. | Ontario COVID-19 Science Advisory Table
Aim: What are the risks of COVID-19 hospitalization, ICU admission and death caused by VOCs as compared with the early variants of SARS-CoV-2?
3/29/21
Brolin K, Cenciarelli O, Colzani E, et al. | European Centre for Disease Prevention and Control
Aim: To provide a summary of the available scientific evidence on the risk of SARS-CoV-2 transmission to susceptible contacts from infected individuals with documented previous infection or vaccination.
3/25/21
 | CADTH
3/25/21
 | Pan American Health Organization
Aim: To review the evidence on potential COVID-19 therapeutics.
3/23/21
Kain D, Stall NM, Allen V, et al. | Science Table COVID-19 Advisory for Ontario
Aim: To review the evidence on routine asymptomatic screen testing of staff as a potential mitigating strategy to reduce SARS-CoV-2 introduction and transmission in LTC homes.
3/23/21
Ryan RE, Parkhill A, Schonfeld L, et al. | Health Evidence Network
Aim: To analyse evidence regarding communication with individuals and communities within the wider structural and sociopolitical context of the pandemic to support public health decision-makers when planning and implementing physical distancing measures.
WHO COLLABORATIVE
3/17/21
 | NSW Health COVID-19 Critical Intelligence Unit
3/17/21
 | NSW Health COVID-19 Critical Intelligence Unit
3/17/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the AstraZeneca vaccine and blood clots.
3/17/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidenceo n the likelihood that SARS-CoV-2 will become endemic.
3/16/21
Meena JP, Gupta AK, Tanwar P, et al. | Pediatr Blood Cancer
Aim: To review the evidence on pediatric cancer patients affected by COVID-19 and analyze the clinical manifestations and outcomes.
UPDATED
3/16/21
Munich J, Dennett L, Swainson J, et al. | Front Psychiatry
Aim: To rapidly synthesize available data on emergency department utilization for psychiatric concerns during COVID-19.
3/16/21
Helvaci N, Eyupoglu ND, Karabulut E, et al.  | Front Endocrinol
Aim: To evaluate the prevalence of obesity in patients with COVID-19 and to stratify the estimates by illness severity.
UPDATED
3/16/21
Hossain A, Nasrullah SM, Tasnim Z, et al. | EClinicalMedicine
Aim: To estimate pooled seroprevalence of SARS-CoV-2 IgG antibodies across geographic regions and to investigate the pattern by age-group, gender, infection risk of HCWs, and study period.
UPDATED
3/16/21
da Silva FCT, Barbosa CP | Prog Neuropsychopharmacol Biol Psychiatry
Aim: To understand the impact that COVID-19 is having on the front-line clinical team in the ICU environment, as well as reveal what proposals are being made to mitigate the clinical and psychological impacts that this group experiences.
3/15/21
Mehta AA, Haridas N, Belgundi P, et al. | Diabetes Metab Syndr
Aim: To provide a comprehensive summary of clinical and laboratory parameters that are associated with and indicative of increased severity among COVID-19 patients.
3/15/21
Marzoli F, Bortolami A, Pezzuto A, et al. | Sci Total Environ
Aim: To summarize all the evidence on surface survival of coronaviruses infecting humans. 
3/15/21
Lim ZJ, Reddy MP, Curtis JR, et al. | Crit Care Med
Aim: To investigate the incidence, characteristics, and outcomes of in-hospital cardiac arrest in patients with coronavirus disease 2019 and to describe the characteristics and outcomes for patients with in-hospital cardiac arrest within the ICU, compared with non-ICU patients with in-hospital cardiac arrest. 
UPDATED
3/15/21
Huntley B, Mulder IA, Di Mascio D, et al. | Obstet Gynecol
Aim: To compare the risk of intrauterine fetal death (20 weeks of gestation or later) and neonatal death among individuals who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compared with those who tested negative for SARS-CoV-2 on admission for delivery.
UPDATED
3/15/21
Karimian M, Azami M | Pol J Radiol
Aim: To evaluate CT scan findings of COVID-19 at the time of admission.
UPDATED
3/15/21
Yang Y, Sun S, Hu S, et al. | Front Psychol
Aim: To compare the different psychological interventions and distinguish the most effective way to treat psychological crisis according to different clinical manifestations in people affected by coronavirus disease 2019 (COVID-19).
3/15/21
Zhang X, Xi L, Pang F, et al. | Iran J Public Health
Aim: To summarize the clinical evidence regarding the efficacy and safety of convalescent plasma therapy in the treatment of severe COVID-19.
3/15/21
Qiang Z, Wang B, Garrett BC, et al. | Curr Opin Cardiol
Aim: To have a greater mortality impact on subgroups of people in the population who are deemed to be at higher medical disease risk.
3/15/21
Pranata R, Huang I, Lim MA, et al. | Arch Gerontol Geriatr
Aim: To establish the association between delirium and mortality in older adults with COVID-19.
UPDATED
3/15/21
Xing K, Tu X, Liu M, et al. | Zhongguo Dang Dai Er Ke Za Zhi
Aim: To evaluate systematically the efficacy and safety of COVID-19 vaccines.
3/15/21
Abate SM, Checkol YA, Mantefardo B | Ann Med Surg
Aim: To provide global evidence on the prevalence and risk factors including age, gender, comorbidity, and substance use on hospital mortality among hospitalized patients with COVID-19.
3/15/21
Syahrul S, Maliga HA, Ilmawan M, et al. | F1000Research
Aim: To determine the global prevalence, chronological order of symptom appearance, and mortality rates with regard to hemorrhagic and ischemic stroke in patients with coronavirus disease 2019 (COVID-19) and to discuss possible pathogeneses of hemorrhagic and ischemic stroke in individuals with the disease.
UPDATED
3/15/21
Yuan J, Qian H, Cao S, et al. | Transl Pediatr
Aim: To investigate the clinical features of pregnant women and their neonates with coronavirus disease 2019 (COVID-19) and the evidence of vertical transmission of COVID-19.
3/15/21
Moran C, Campbell DJT, Campbell TS, et al. | J Public Health
Aim: To identify predictors of attitudes toward and adherence to COVID-19 public health guidelines, and identify interventions aiming to improve adherence.
3/15/21
Alene M, Yismaw L, Assemie MA, et al. | BMC Infect Dis
Aim: To determine the overall pooled mean serial interval and incubation period of COVID-19 using available evidences.
3/15/21
Dorward J, Gbinigie O, Cai T, et al. | Antivir Ther
Aim: To synthesise the clinical evidence for lopinavir/ritonavir as a treatment for COVID-19.
3/15/21
Stanoeva KR, van der Eijk AA, Meijer A, et al. | Euro Surveill
Aim: To review current published knowledge on the kinetics of SARS-CoV-2 infection as assessed by RNA molecular detection in a wide range of clinical samples.
3/11/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of the AstraZeneca vaccine, particuarly regarding hospitalisations in the United Kingdom.
3/10/21
Chou R, Dana T, Jungbauer R, et al. | Ann Intern Med
Aim: To examine the effectiveness of N95, surgical, and cloth masks in community and health care settings for preventing respiratory virus infections, and effects of reuse or extended use of N95 masks.
UPDATED
3/8/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of the COVID-19 pandemic on the publication of pre-peer review articles and the quality of research evidence.
3/8/21
Skapetis T, Law C, Rodricks R, et al. | BMC Med Ethics
Aim: To determine the ethical challenges associated with conducting medical research in low COVID-19 prevalence countries.
3/5/21
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how long the COVID-19 virus can survive with potential for infection on surfaces found in community settings.
3/4/21
Park JY, Freer R, Stevens R, et al.  | Oxford COVID-19 Evidence Service
3/1/21
Gupta N, Balcom S, Gulliver A, et al. | Int J Health Planning Manag
Aim: To assess the state of the evidence on policy and planning responses to HRH surge capacity during the coronavirus disease (COVID?19) pandemic and other viral respiratory disease outbreaks of global significance in the 21st century.
UPDATED
3/1/21
Morris AM, Stall NM, Bobos P, et al. | Ontario COVID-19 Science Advisory Table
Aim: Does tocilizumab improve patient outcomes such as mortality, need for mechanical ventilation, requirement for organ support, intensive care unit (ICU) length of stay, and hospital length of stay for individuals hospitalized with COVID-19? 
2/28/21
 | Penn Medicine’s Center for Evidence-based Practice
Aim: To identify pathways, algorithms, and clinical risk prediction tools that can be used in Emergency Department triage of patients with suspected or confirmed COVID-19 disease and to review the evidence on their effectiveness.
2/25/21
Schiff JW | CMH Initiative
2/23/21
 | CADTH
Aim: To review the evidence on tocilizumab and sarilumab for their potential use in managing COVID-19.
2/22/21
Puyat JH, Ahmad H, Kazanjian H | CMH Initiative
Aim: To investigate home-based activities that have protective and therapeutic effects against mental health symptoms during pandemics and to identify if there are activities that are effective for specific groups.
2/19/21
Dotto L, de Azevedo Kinalski M, Machado PS, et al. | J Evid Based Med
Aim: To assess the characteristics of different designs of systematic reviews (SRs) registered in the International Prospective Register of Systematic Reviews (PROSPERO) about COVID-19.
2/17/21
Kumar D, Severn M | CADTH
2/16/21
Labad J, Gonzalez-Rodriguez A, Cobo J, et al.  | PeerJ
Aim: To explore whether the coronavirus disease 2019 (COVID-19) pandemic is associated with toilet paper hoarding and to assess which risk factors are associated with the risk of toilet paper hoarding.
UPDATED
2/16/21
Sarria-Guzman Y, Fusaro C, Bernal JE, et al. | J Infect Dev Ctries
Aim: To identify and to evaluate the reports associated on Knowledge, Attitude and Practices (KAP) towards COVID-19 pandemic in America.
2/13/21
Chowdhury P, Paul SK, Kaisar S, et al. | Transp Rep E Logist Transp Rev
Aim: To  systematically review existing research on the COVID-19 pandemic in supply chain disciplines.
2/11/21
Bauer M, Groesdonk HV, Preissing F, et al. | Anaesthesist
Aim: To estimate 30-day and 90-day mortality of patients with sepsis and patients with septic shock in Germany and to compare the mortality with that of other industrialized regions (Europe, North America).
2/10/21
 | NSW Health COVID-19 Critical Intelligence Unit
2/8/21
Dabone C, Mbagwu I, Muray M, et al. | J Racial Ethn Health Disparities
Aim: To assess the food insecurity conditions of ACB populations globally during the COVID-19 pandemic.
2/8/21
 | NSW Health COVID-19 Critical Intelligence Unit
2/3/21
 | CMH Initiative
2/3/21
Lopez-Valenciano A, Suarez-Iglesias D, Sanchez-Lastra MA, et al. | Front Psychol
Aim: To analyze the impact that the COVID-19 lockdown had on the amount of physical activity performed by university students.
2/3/21
Pourmalek F, Hemami MR, Janani L, et al. | BMC Public Health
Aim: To inform the researchers about the methodology and results of epidemic estimation studies performed for COVID-19 epidemic in Iran, we aimed to perform a rapid review.
UPDATED
1/29/21
Yu YJ, Park YS, Keller A, et al. | Int J Environ Res Public Health
Aim: To synthesize existing findings (both qualitative and quantitative) that focus on the social and cultural impacts of coronaviruses in order to gain a better understanding of the COVID-19 pandemic.
1/29/21
Raynaud M, Zhang H, Louis K, et al. | BMC Med Res Methodol
Aim: To review and categorize COVID-19-related medical research and to critically appraise peer-reviewed original articles.
1/29/21
Vargo D, Zhu L, Benwell B, et al. | Human Behaviour and Emerging Technologies
Aim: To synthesize the rapidly growing literature on digital technology use during the current COVID?19 pandemic. To address the following four topics: (1) the specific digital technologies that have been used, (2) the specific populations who have used these digital technologies, (3) the specific activities that individuals and groups have used these digital technologies, and (4) the specific effects of using these digital technologies on humans during the pandemic.
1/29/21
Lim MA, Mulyadi Ridia KG, Pranata R | J Clin Orthop Trauma
Aim: To evaluate the 30-day mortality, number and site of fracture, mechanism of injury, and location where injury was sustained during the pandemic compared to pre-pandemic.
1/27/21
Illahi U, Mir MS | Environ Dev Sustain
Aim: To identify and enhance the understanding of the logistical characteristics that play a vital role during pandemics. 
1/25/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy, safety and rollout of COVID-19 vaccines.
1/22/21
Parry M, Bjornnes AK, Nickerson N, et al. | IRSC CIHR
Aim: To determine what is known about the mental health and wellbeing of family caregivers during communicable disease outbreaks.
1/21/21
Baradaran A, Malek A, Moazzen N, et al. | Iran J Allergy Asthma Immunol
Aim: To describe clinical manifestation and outcomes of MIS-C associated with COVID-19.
1/21/21
Ho JSY, Fernando DI, Chan MY, et al. | Ann Acad Med Singap
Aim: To investigate the relationship between COVID-19 and obesity.
1/21/21
Zare ME, Wang Y, Kansestani AN, et al. | Iran J Allergy Asthma Immunol
Aim: To determine the accuracies of white blood cell counts and inflammatory biomarkers for prognosis of COVID-19 patient's outcome by a DTA meta-analysis.
1/20/21
Zolopa C, Hoj S, Bruneau J, et al. | Int J Drug Policy
Aim: To review the impacts of Big Events with relevance to the COVID-19 pandemic on drug-related risk and harms and access to drug treatment and harm reduction services.
1/19/21
Kheirabadi D, Haddad F, Mousavi-Roknabadi RS, et al. | J Med Virol
Aim: To clarify which systematic reviews on COVID?19 treatment are based on high?value evidence.
1/19/21
von Philipsborn P, Biallas R, Burns J, et al. | BMJ Open
Aim: To assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events , on acute healthcare utilization, as well as on quality of life and long-term survival.
WHO COLLABORATIVE
1/19/21
Duz ME, Balci A, Menekse E | Tuberk Toraks
Aim: To review the evidence on D-dimer levels and mordidity and mortality in COVID-19 patients.
1/19/21
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the infectivity, virulence, and effectiveness of the current vaccines against the new SARS-CoV-2 variants.
1/16/21
Lin Y, Chen C, Wu S | J Med Internet Res
Aim: To review the efficiency and quality of data collection in the existing literature.
1/15/21
Goldstein KM, Ghadimi K, Mystakelis H, et al. | VA Evidence Synthesis Program
Aim: To review the evidence on the risk of transmitting SARS-CoV-2, SARS, MERS, and influenza with administration of drugs via nebulizer
UPDATED
VA ESP
1/14/21
???? P, ?????? H, ???????????? A, et al. | Russian Journal of Infection and Immunity
Aim: To determine the COVID-19 epidemiology, clinical features, diagnosis and treatment.
1/13/21
Lee DS, Mirmirani P, McCleskey PE, et al. | Dermatol Online J
Aim: To identify case reports and case series characterizing cutaneous manifestations of confirmed COVID-19.
1/9/21
Wittenberg E, Goldsmith JV, Chen C, et al. | Patient Educ Couns
Aim: To determine the content of provider communication resources and peer-reviewed articles on COVID-19 communication in order to identify opportunities for developing future COVID-19 communication curricula and support tools.
1/8/21
Abubakar AR, Sani IH, Godman B, et al. | Infect Drug Resist
Aim: To summarize some evidence-based therapeutic options for COVID-19 infection.
1/5/21
Mishra P, Tomar A, Kumar A, et al. | Saudi Journal of Anaesthesia
Aim: To review the evidence on effective pain management in pediatric patients suffering from SARS-CoV-2 virus symptoms.
1/4/21
Rahimi NR, Fouladi-Fard R, Aali R, et al. | Environ Res
Aim: To highlight how the virus is impacted by the environment and how the virus has impacted the environment.
1/4/21
Cascino F, Hoxhaj I, Zace D, et al.  | BMJ Glob Health
Aim: To identify healthcare systems interventions, experiences and recommendations that have been used to manage different respiratory viral infections outbreaks in the past.
UPDATED
1/4/21
Lee KH, Kim SJ, Hong SH, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze the same clinical issues through an improved research method and to find out the differences from the retracted papers.
1/4/21
Dillman A, Zoratti MJ, Park JJH, et al. | Infect Drug Resist
Aim: To summarize and characterize research efforts with respect to the different stages of disease progression.
1/2/21
Farrukh L, Mumtaz A, Sana MK | Rev Med Virol
Aim: To review the evidence on potential reasons why the results of the SARS?CoV?2 RT?PCR tests were positive again in recovered patients.
1/2/21
Wynants L, Van Calster B, Bonten MMJ | BMJ
Aim: To review and critically appraise published and preprint reports of models that aim to predict either (i) presence of existing COVID-19 infection, or (ii) future complications in individuals already diagnosed with COVID-19
UPDATED
1/1/21
Dwipayana, I. D. A. P., Sutarini, I. D. A. A. D. | Jurnal Berkala Epidemiologi
Aim: To discuss the available options that can be taken to vaccinate immunosuppressed cancer patients when no vaccine is being developed for their safety.
12/30/20
Verdugo-Paiva F, Acuna MP, Sola I, et al. | Medwave
Aim: To provide a timely, rigorous and continuously updated summary of the evidence available on the role of remdesivir in the treatment of patients with COVID-19.
12/23/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of ivermectin for prophylaxis or treatment of COVID-19.
12/23/20
Kubota T, Gajera PK, Kuroda N | Epilepsy Behav
Aim: To perform a systematic review and meta-analysis to summarize and quantitatively evaluate the electroencephalogram (EEG) findings in patients with coronavirus disease 2019 (COVID-19).
12/22/20
Fiest KM, Krewulak KD, Plotnikoff KM, et al. | BMC Med
Aim: To evaluate the validity of published triage protocols and the mortality prediction embedded within them to help inform health system-decision-making.
12/22/20
Clark M, Loshak H, Farrah K | CADTH
Aim: To review the evidence on the use of COVID-19 mRNA vaccines on patients with cancer or who are immunocompromised.
12/22/20
Raymond C, Loshak H | CADTH
Aim: To describe the trial characteristics and estimated primary completion dates of the ongoing phase II, phase III, and phase IV studies evaluating IVIg and hyperimmune globulin to treat COVID-19.
UPDATED
12/22/20
West E, Moore K, Kupeli N, et al. | Age Aging
Aim: To explore key factors that influence place of care and place of death decisions in older adults.
12/18/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the impact of COVID-19 and related public health measures on household food security.
UPDATED
12/16/20
Cowling T, Graves E, Loshak H | CADTH
Aim: To explore what we know about virus-neutralizing monoclonal antibodies, their mechanism of action and how they are administered, and which virus-neutralizing monoclonal antibodies are in clinical development for SARS-CoV-2 infection.
12/14/20
Gallagher JE, Sukriti KC, Johnson IG, et al. | BDJ Open
Aim: To review the evidence on the pattern of aerosol spread and settle relevant to oral surgery in dental surgery.
UPDATED
12/11/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on risk factors are associated with COVID-19 outbreaks and mortality in LTC facilities and what strategies mitigate risk.
UPDATED
12/11/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how and by whom COVID-19 is introduced and transmitted within acute care settings.
12/10/20
 | NSW Health COVID-19 Critical Intelligence Unit
12/10/20
Levin AT, Hanage WP, Owusu-Boaitey N, et al. | Eur J Epidemiol
Aim: To assess the age specificity of the infection fatality rate (IFR) for COVID-19 using seroprevalence results from eight national studies (Belgium, England, Hungary, Italy, Netherlands, Portugal, Spain, and Sweden), fifteen seroprevalence studies of specific locations in Europe and the United States, and three countries (Iceland, New Zealand, and Republic of Korea) that have engaged in comprehensive tracking and tracing of COVID-19 infections.
UPDATED
12/10/20
Liu N, Sun J, Wang X, et al. | J Alzheimers Dis
Aim: To investigate the impact of pre-existing dementia comorbidities on COVID-19.
12/9/20
Kondylakis H, Katehakis DG, Kouroubali A, et al. | J Med Internet Res
Aim: To shed light into studies found in the scientific literature that have used and evaluated mobile apps for the prevention, management, treatment, or follow-up of COVID-19.
12/9/20
 | NSW Health COVID-19 Critical Intelligence Unit
12/9/20
El Keshky MES, Basyouni SS, Al Sabban AM | Front Psychol
Aim: To evaluate the impact of COVID-19 on the psychology of sustainability (quality of life), on sustainable development, and on the global economy. 
12/9/20
Vancsa S, Hegyi PJ, Zadori N, et al. | Front Med
Aim: To evaluate the prognostic value of on-admission liver function tests and pre-existing liver diseases on the clinical course of coronavirus disease 2019 (COVID-19).
UPDATED
12/9/20
Putko RM, Bedrin MD, Clark DM, et al. | J Clin Orthop Trauma
Aim: To identify risk factors, comorbidities, case characteristics, and treatment strategies to better understand the nature of this disease and its effects on the extremities.
12/9/20
Prakash A, Singh H, Kaur H, et al. | Indian J Psychiatry
Aim: To evaluate the efficacy and safety of FPV in published literature.
12/9/20
Shamshirian A, Hessami A, Heydari K, et al. | Ann Acad Med Singap
Aim: To examine the effectiveness of hydroxychloroquine in treatment of COVID-19.
UPDATED
12/9/20
Fligor SC, Tsikis ST, Wang S, et al. | J Thorac Dis
Aim: To synthesize the available literature on time to surgery and its impact on outcomes along with a critical appraisal of the released triage guidelines in the United States.
12/8/20
Wilkinson R, Hines L, Holland A, et al.  | Harm Reduct J
Aim: To explore what harm reduction interventions and messaging are most effective during a pandemic-type situation.
UPDATED
12/7/20
Puyat J, Ahmad H, Avina-Galindo AM, et al | PLoS One
Aim: To review the evidence on home-based activities that have potential beneficial effects on mental health.
UPDATED
12/7/20
Hessami A, Shamshirian A, Heydari K, et al. | Am J Emerg Med
Aim: To study cardiovascular disease burden among COVID-19 patients.
UPDATED
12/7/20
Rodriguez-Gonzalez M, Castellano-Martinez-A, Cascales-Poyatos HM, et al. | World J Clin Cases
Aim: To summarize the current knowledge about the potential cardiovascular involvement in pediatric COVID-19 in order to give a perspective on how to take care of them during the current pandemic emergency.
12/7/20
Kim JS, Lee KH, Kim GE, et al. | Eur Rev Med Pharmacol Sci
Aim: To analyze clinical characteristics and mortality of patients with hematologic malignancies and COVID-19.
12/7/20
Vakhshoori M, Emami SA, Heidarpour M, et al. | Iran J Kidney Dis
Aim: To define the frequency of AKI as well as two specific renal biomarkers including BUN and serum Cr among individuals suffering from COVID-19 infection. 
12/7/20
Hu BS, Hu MZ, Jiang LX, et al. | Eur Rev Med Pharmacol Sci
Aim: To review the evidence on the use of ECMO in patients with COVID-19.
12/7/20
Ampuero J, Sanchez-Torrijos Y, Del Rosario Garcia Lozano M, et al. | Rev Esp Enferm Dig
Aim: To assess the impact of the baseline liver function (AST, ALT, and bilirubin) on COVID-19-related outcomes, including on mortality, intensive care unit admission, and non-fatal severe complications.
12/7/20
Bandyopadhyay S, Baticulon RE, Kadhum M, et al. | BMJ Glob Health
Aim: To estimate COVID-19 infections and deaths in healthcare workers (HCWs) from a global perspective during the early phases of the pandemic.
12/7/20
Berardicurti O, Ruscitti P, Ursini F, et al. | Clin Exp Rheumatol
Aim: To review the evidence on the mortality rate in TCZ-treated patients with COVID-19.
12/7/20
Chu Y, Yang J, Shi J, et al. | Eur J Med Res
Aim: To investigate the association between obesity and poor outcomes in patients with COVID-19 pneumonia.
12/7/20
 | NSW Health COVID-19 Critical Intelligence Unit
12/7/20
Jefferson T, Spencer EA, Brassey J, et al. | Clin Infect Dis
Aim: To review the evidence from studies relating SARS-CoV-2 culture with the results of reverse transcriptase polymerase chain reaction (RT-PCR) and other variables which may influence the interpretation of the test, such as time from symptom onset.
UPDATED
12/4/20
Shuto H, Komiya K, Yamasue M, et al. | Sci Rep
Aim: To review the evidence on the associations between corticosteroid treatment and any type of mortality and/or other clinical outcomes among noncritically ill patients with COVID-19.
12/4/20
Zarifkar P, Kamath A, Robinson C, et al. | Clin Oncol
Aim: To review the current evidence base pertaining to the prevalence, presentation and outcome of COVID-19 in cancer patients, in order to inform policy and practice going forwards.
UPDATED
12/4/20
Mohamed K, Yazdanpanah N, Saghazadeh A, et al. | Bioorg Chem
Aim: To provide an overview of studies that have used computational methods for drug repurposing in COVID-19.
12/4/20
da Silva FAF, de Brito BB, Santos MLC, et al. | Rev Soc Bras Med Trop
Aim: To review the evidence on GI symptoms associated with coronavirus disease 2019 (COVID-19) as well as of the serum levels of biomarkers related to liver function and lesion in SARS-CoV-2-infected individuals.
12/4/20
Alhumaid S, Al Mutair A, Al Alawi Z, et al. | Trop Med Infect Dis
Aim: To assess the efficacy and safety of lopinavir/ritonavir in COVID-19 patients in the extant published research.
UPDATED
12/4/20
Pollock A, Campbell P, Cheyne J, et al. | Cochrane Database Syst Rev
Aim: To review the evidence on the effects of interventions aimed at supporting the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic.
12/4/20
Komolafe TE, Agbo J, Olaniyi EO, et al. | Diagnostics
Aim: To perform a meta-analysis to evaluate the diagnostic performance of chest CT, common CT morphological abnormalities, disease prevalence, biodata information, and gender prevalence of patients.
UPDATED
12/4/20
Zuercher SJ, Kerksieck P, Adamus C, et al. | Front Public Health
Aim: To review the evidence on MHP prevalence rates published since 2000, during and after epidemics, including the general public, health care workers, and survivors.
UPDATED
12/4/20
National Collaborating Centre for Methods and Tools | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on the use and cessation of tobacco and vaping products.
12/4/20
Lieneck C, Garvey J, Collins C, et al. | Healthcare
Aim: To evaluate the literature specific to rapid telehealth implementation during the current COVID-19 pandemic.
12/4/20
Lo Moro G, Sinigaglia T, Bert F, et al. | Int J Environ Res Public Health
Aim: To describe the main measures planned for the 2020–2021 academic year within the WHO European Region.
12/4/20
Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, et al. | Pulmonology
Aim: To determine the prevalence of restrictive pattern, obstructive pattern and altered diffusion in patients post-COVID-19 infection and to describe the different evaluations of respiratory function used with these patients.
UPDATED
12/4/20
John A, Okolie C, Eyles E, et al. | F1000Research
Aim: To identify and appraise any newly published evidence from around the world that assesses the impact of the COVID-19 pandemic on suicide deaths, suicidal behaviours, self-harm and suicidal thoughts, or that assesses the effectiveness of strategies to reduce the risk of suicide deaths, suicidal behaviours, self-harm and suicidal thoughts, resulting from the COVID-19 pandemic.
12/4/20
Yifan C, Jun P | Front Endocrinol
Aim: To assess the clinical characteristics of elder patients with COVID-19.
12/4/20
Foldi M, Farkas N, Kiss S, et al. | Obesity
Aim: To evaluate the association between the distributions of CT?quantified fat mass and critical condition of patients with COVID?19.
12/3/20
Oakman J, Kinsman N, Stuckey R, et al. | BMC Public Health
Aim: To review the impact of WAH on individual workers’ mental and physical health, and determine any gender difference, to develop recommendations for employers and employees to optimise workers’ health.
12/3/20
Jain N, Varman R, Tarbox JA, et al. | Auris Nasus Larynx
Aim: To review the current knowledge of biomolecular factors surrounding otorhinolaryngeal illnesses and analyze their presence in COVID-19 virulence. 
12/3/20
Szarpak L, Adam I, Dzieciatkowski T, et al. | Postepy Nauk Medycznych
Aim: To identify the most frequently observed symptoms in pediatric patients with confirmed COVID-19.
12/3/20
Chi J, Gong W, Gao Q | Arch Gynecol Obstet
Aim: To summarize the clinical features and maternal–infant outcomes of 230 pregnant women (154 patients gave birth) infected with COVID-19 and their 156 infants, including the possibility and evidence of vertical transmission.
12/3/20
Zhou S, Xu J, Xue C, et al. | Ren Fail
Aim: To review the evidence on kidney-related outcomes of three recent pandemics: SARS, MERS, and COVID-19, which were associated with potentially fatal acute respiratory distress syndrome (ARDS).
UPDATED
12/3/20
Cai XJ, Tay JCK, Kui SL, et al. | Singapore Med J
Aim: To study in-hospital mortality in COVID-19 patients who were on ACEI/ARB as compared to those not on ACEI/ARB.
12/3/20
do Amaral WN, de Moraes CL, Dos Santos Rodrigues AP, et al. | Healthcare
Aim: To investigate pregnant women infected with COVID-19 in terms of signs and symptoms, type of delivery, comorbidities, maternal and neonatal outcomes, and the possibility of vertical transmission.
12/3/20
Aburas W, Alshammari TM | Saudi Pharm J
Aim: To provide an overview of pharmacists’ roles in disasters and formulating a definition of expected roles and tasks through which they can perform these roles properly.
12/3/20
Mahdi SS, Ahmed Z, Allana R, et al. | Medicina
Aim: To identify additional infection control measures implemented in dental practice globally to prevent cross-infection and evaluate the psychological impacts of the pandemic among dental professionals.
12/2/20
Fraiman P, Godeiro C, Moro E, et al. | Front Neurol
Aim: To review the evidence on the cerebrovascular events in COVID-19 infection.
12/2/20
Gunn H, McCormack S | CADTH
12/2/20
Zhou L, Wang J, Xie R, et al. | J Altern Complement Med
Aim: To assess the effects of TCM as an auxiliary treatment for COVID-19 through a systematic review of randomized-controlled trials (RCTs).
UPDATED
12/2/20
Malas MB, Naazie IN, Elsayed N, et al. | EClinicalMedicine
Aim: To estimate the overall rates of TE of COVID-19 and further determine the association of TE with mortality among patients with COVID-19.
12/1/20
Schunemann HJ, Khabsa J, Solo K, et al. | Ann Intern Med
Aim: To review multiple streams of evidence regarding the benefits and harms of ventilation techniques for coronavirus infections, including that causing COVID-19.
UPDATED
11/30/20
Graber K, Byrne E, Goodacre E, et al. | Child Care Health Dev
Aim: To review of the impact of quarantine, isolation, or other restrictive environments on children’s play and whether play may mitigate the adverse effects of such restrictions.
UPDATED
11/30/20
da Rosa Mesquita R, Silva LCF, Santana FMS, et al. | Wien Klin Wochenschr
Aim: To systematize the literature regarding clinical manifestations of patients with confirmed COVID-19.
11/30/20
Wang Z, Deng H, Ou C, et al. | Medicine
Aim: To compare the differences in the field of demographic, comorbidities, clinical symptoms, complications and outcomes between severe and non-severe COVID-19.
11/30/20
Raja MA, Mendoza MA, Villavicencio A, et al. | Transplant Rev
Aim: To help expand our current limited knowledge base regarding COVID-19 in SOT recipients, especially looking at clinical presentations, treatment modalities and outcomes.
11/30/20
Meher BR, Padhy BM, Das S, et al. | J Assoc Physicians India
Aim: To evaluate the currently available data to provide evidence about CPT in COVD-19 patients. 
11/30/20
Amiri-Dashatan N, Koushki M, Ghorbani F, et al. | Gastroenterol Hepatol Bed Bench
Aim: To determine whether patients with elevated CRP, TNF?, and IL-6 levels may be at increased risk for severe infection and liver damage of COVID-19.
11/30/20
Makvandi S, Ashtari S, Vahedian-Azimi A | Gastroenterol Hepatol Bed Bench
Aim: To evaluate the symptoms of COVID-19 in pregnant women with a focus on gastrointestinal symptoms.
11/30/20
Bell V, Wade D | Soc Psychiatr Epidemiol
Aim: To estimate the additional burden of working directly with infected patients during epidemic and pandemic health emergencies.
UPDATED
11/30/20
Hannum ME, Ramirez VA, Lipson SJ, et al. | Chem Senses
Aim: To provide a comprehensive assessment of methodologies currently employed to quantify smell loss in COVID-19–positive patients and examine whether method type affects reported prevalence of smell loss in COVID-19 patients.
UPDATED
11/30/20
Mousquer GT, Peres A, Fiegenbaum M | Tuberculosis
Aim: To conduct a systematic review on the current literature on TB/COVID-19 co-infection cohorts, evaluating clinical and epidemiological data, focusing on its implications to the immune system.
11/30/20
Bekele F, Sheleme T, Fekadu G, et al. | SAGE Open Med
Aim: To summarize the knowledge, attitudes, and practice of COVID-19 among the general population and health workers across the globe.
11/30/20
Afra HS, Amiri-Dashatan N, Ghorbani F, et al. | Gastroenterol Hepatol Bed Bench
Aim: To report a pooled analysis of the association of the circulating levels of liver enzymes and total bilirubin with severe and non-severe COVID-19.
11/30/20
Bareeqa SB, Ahmed SI, Samar SS, et al. | Int J Psychiatry Med
Aim: To quantify COVID-19 mental health issues and its prevalence in China during the early period of the COVID-19 crisis.
UPDATED
11/30/20
Thrinuavukkarasu S, Kapoor N, Tina Cao, et al. | Diabetes Obes Metab
Aim: To examine the proportion of newly diagnosed diabetes in COVID-19 patients.
11/30/20
Azam M, Sulistiana R, Ratnawati M, et al. | Sci Rep
Aim: To estimate the incidence of recurrent SARS-CoV-2 RNA positivity after recovery from COVID-19 and to determine the factors associated with recurrent positivity. 
UPDATED
11/30/20
Maraolo AE, Grosi A | Immun Inflamm Dis
Aim: To gauge the safety profile of HCQ/CQ in the context of COVID?19 pandemic on the basis of data from RCTs published so far, to highlight the trade?off between pros and cons of HCQ/CQ repurposing to treat or prevent SARS?CoV?2 infection.
11/30/20
Jammu A, Chasen M, Lofters A, et al. | Support Care Cancer
Aim: To synthesise the available knowledge regarding the impact of the COVID-19 pandemic.
UPDATED
11/30/20
Cardwell K, Jordan K, Byrne P, et al. | Rev Med Virol
Aim: To summarise the evidence on non?contact thermal screening as a method through which to identify cases and reduce the spread of coronavirus disease (Covid?19).
11/30/20
Allan SM, Bealey R, Birch J, et al. | Eur J Psychotraumatol
Aim: To estimate the prevalence of common mental health disorders in HCWs based in hospitals where pandemic-affected patients were treated.
UPDATED
11/27/20
Arruda AG, Beyene TJ, Kieffer J, et al. | Animals
Aim: To summarize the available literature on swine depopulation methods and to highlight critical gaps in knowledge.
11/27/20
Griffin J, Casey M, Collins Á, et al. | BMJ Open
Aim: To conduct a review of available evidence to advise on appropriate parameter values for serial interval and generation time in national COVID-19 transmission models for Ireland and on methodological issues relating to those parameters.
UPDATED
11/24/20
France R, Vseteckova J, Lapwood S, et wood | Oxford COVID-19 Evidence Service
11/23/20
Thombs BD, Bonardi O, Rice DB, et al. | IRSC CIHR
Aim: To review the evidence on the impact of the COVID-19 pandemic on mental health.
11/20/20
Rezapour A, Souresafil A, Peighambari MM, et al.  | Int J Surg
Aim: To summarize economic evaluation evidence of preventing strategies, programs, and treatments of COVID-19.
11/20/20
Camden C, Malboeuf-Hurtubise C, Roberge P, et al. | IRSC CIHR
Aim: To explore the impacts of the context pandemic including sanitary measures and confinement on the mental health of children aged 5 to 12 years.
11/19/20
Mair M, Singhavi H, Pai A, et al. | Laryngoscope
Aim: To examine the pooled prevalence of symptoms, laboratory tests, and imaging of all COVID-19 infected patients.
11/18/20
Serafim RB, Póvoa P, Souza-Dantas V, et al. | Clin Microbiol Infect
Aim: To describe the clinical course and outcomes of COVID-19 pneumonia in critically ill patients.
UPDATED
11/18/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for transmission of COVID-19 in different settings, and to determine which settings are high risk.
11/18/20
Spencer N, Nathawad R, Arpin E, et al. | BMJ Paediatr Open
Aim: To review the evidence on the impact of pandemics on existing inequities in routine vaccination coverage.
11/16/20
Yoon YK, Lee J, Kim SI, et al  | J Korean Med Sci
Aim: To derive suggestions for short-, mid-, and long-term strategies for medical resource management beyond the COVID-19 pandemic.
11/16/20
Pant S, Perras C | CADTH
Aim: To describe the trial characteristics and estimated primary completion dates of the ongoing phase II, phase III, and phase IV studies evaluating drugs to prevent or treat COVID-19.
UPDATED
11/15/20
Flodgren GM, Vestrheim DF, Brurberg KG | Norwegian Institute of Public Health
Aim: To review the evidence on the risk factors for severe COVID-19 disease.
11/12/20
Wang K, Wu C, Xu J, et al. | EClinicalMedicine
Aim: To describe the clinical outcomes of operative patients with COVID-19, and the safety of medical staff during the perioperative period to take appropriate protective measures to avoid cross-infection.
11/12/20
Fredericks S, Miranda J, Sidani S, et al. | Brain Behav Immun Health
Aim: To inform evidence-based decision-making pertaining to the selection of effective strategies or therapies that this cohort could use to promote mental health and resilience both within the clinical practice and academic environment.
11/12/20
Hong TS, Gonzalez J, Nahass RG, et al. | Pharmacy
Aim: To evaluate the impact of HCQ exposure on mortality in hospitalized patients with COVID-19. 
11/11/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on monitoring wastewater as a surveillance strategy for COVID-19.
11/9/20
Kiss P, Carcel C, Hockham C, et al. | Eur Heart J Qual Care Clin Outcomes
Aim: To assess the extent to which health services related to the care and management of acute cardiovascular events have been impacted during the COVID-19 pandemic.
11/6/20
Santos M, Torres D, Cardoso PC, et al. | Braz Oral Res
Aim: To investigate the efficiency of cloth masks in reducing transmission and contamination by droplets and aerosols for the general population and healthcare workers.
11/6/20
Mallett S, Allen J, Graziadio S, et al. | BMC Med
Aim: To examine at what time points during SARS?CoV?2 infection it is detectable at different anatomical sites using RT?PCR based tests.  
UPDATED
11/6/20
Yadav R, Srivastava DK, Bajpai PK, et al. | J Neurosci Rural Pract
Aim: To determine the neurological involvement and its manifestations in COVID-19 patients.
11/6/20
Pereira M, Damascena AD, Azevedo LMG, et al. | Crit Rev Food Sci Nutr
Aim: To analyze the association between vitamin D deficiency and COVID-19 severity, via an analysis of the prevalence of vitamin D deficiency and insufficiency in people with the disease. 
11/5/20
Mirza FN, Malik AA, Omer SB, et al. | Int J Dermatol
Aim: To collate the available information on the dermatologic manifestations in COVID?19 patients to inform current practice and further research.
UPDATED
11/5/20
Cheruiyot I, Sehmi P, Ominde B, et al  | Neurol Sci
Aim: To identify and consolidate evidence of ICH in COVID-19 patients.
11/5/20
Alamoodi AH, Zaidan BB, Zaidan AA, et al. | Expert Syst Appl
Aim: To review and analyse articles about the occurrence of different types of infectious diseases, such as epidemics, pandemics, viruses or outbreaks, during the last 10 years, understand the application of sentiment analysis and obtain the most important literature findings.
11/4/20
Park R, Lee S, Kim SY, et al  | Acta Oncol
Aim: To summarize the existing evidence for the effect of active oncologic treatment on COVID-19 outcomes.
UPDATED
11/4/20
Zhang H, Han H, He T, et al. | J Natl Cancer Inst
Aim: To review the evidence on the reported fatalities in COVID-19 patients with cancer.
11/4/20
Cao K, Kline B, Han Y, et al. | Biomed Res Int
Aim: To estimate the prevalence rate of ocular symptoms and the positive rate of conjunctival swab samples of patients diagnosed with 2019 Novel Coronavirus Disease (COVID-19).
11/4/20
 | NSW Health COVID-19 Critical Intelligence Unit
11/4/20
Hoang T | J Med Virol
Aim: To summarize the current evidence of factors associated with the risk of disease recurrence.
11/4/20
Khateri S, Mohammadi H, Khateri R, et al. | Arch Acad Emerg Med
Aim: To determine the prevalence of underlying diseases and associated comorbidities in COVID-19 patients using a systematic review and meta-analysis.
11/4/20
Bashash D, Hosseini-Baharanchi FS, Rezaie-Tavirani M, et al. | Arch Acad Emerg Med
Aim: To provide a well-conceptualized viewpoint demonstrating the prognostic value of thrombocytopenia in COVID-19.
11/2/20
Boregowda U, Perisetti A, Nanjappa A, et al. | Front Med
Aim: To compare the efficacy of tocilizumab in severe COVID-19 cases vs. standard of care alone.
UPDATED
11/2/20
Dawoud DM, Soliman KY | Value Health
Aim: To review published economic evaluations of antiviral treatment for pandemics and outbreaks of respiratory illnesses.
11/2/20
Saad MA, Alfishawy M, Nassar M, et al. | Curr Rheumatol Rev
Aim: To review the evidence on reported COVID-19 cases with asociated autoimmune manifestations.
11/2/20
Palaiodimos L, Chamorro-Pareja N, Karamanis D, et al. | Hormones
Aim: To systematically review and synthesize with a meta-analysis the available observational studies reporting the effect of diabetes in mortality among hospitalized patients with COVID-19.
UPDATED
11/2/20
Elsawah H, Elsokary M, Abdallah MS, et al. | Rev Med Virol
Aim: To systematically review the use of remdesivir in Covid?19 among the available clinical trials and summarise remdesivir efficacy.
UPDATED
11/2/20
Hariyanto TI, Kristine E, Jillian C, et al. | Infect Disord Drug Targets
Aim: To review the evidence on the use of lopinavir/ritonavir as a potential treatment candidate against COVID-19.
11/2/20
Megnin-Viggars O, Carter P, Melendez-Torres GJ, et al. | PLoS One
Aim: To identify facilitators and barriers to uptake of, and engagement with, contact tracing during infectious disease outbreaks.
11/2/20
Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, et al. | Diseases
Aim: To explore the incidence of acute myocardial injury among COVID-19 patients.
11/2/20
Cagnazzo F, Arquizan C, Derraz I, et al. | J Neurol
Aim: To perform an updated review of the literature on the neurological manifestations of COVID-19-infected patients
11/2/20
Trypsteen W, Van Cleemput J, Van Snippenberg W, et al. | PLoS One
Aim: To review the current (pre)published SARS-CoV-2 literature with a focus on the evidence concerning SARS-CoV-2 distribution in human tissues and viral shedding in body fluids.
11/2/20
Shrestha DB, Budhathoki P, Syed N, et al. | Life Sci
Aim: To conduct a systematic review and meta-analysis on remdesivir use for COVID-19.
11/2/20
Ciaffi J, Meliconi R, Ruscitti P, et al. | BMC Rheumatol
Aim: To assess the prevalence of rheumatic manifestations in patients affected by COVID-19, as initial symptom or during disease course.
11/2/20
Lee KW, Khan AHKY, Ching SW, et al. | Front Neurol
Aim: To perform a systematic review and meta-analysis of currently available epidemiological, clinical, and laboratory data related to both stroke and COVID-19 infection.
11/2/20
Violante T, Violante FS | Med Lav
Aim: To summarize the available studies which have compared the respective effectiveness of surgical masks and filtering facepiece respirators  for the prevention of infections caused by viruses that are transmitted by the respiratory tract.
11/2/20
Antony AR, Haneef Z | Seizure
Aim: To synthesize the data on EEG findings in COVID-19.
11/2/20
Kolcun JPG, Ryu WHA, Traynelis VC | J Neurosrug Spine
Aim: To examine the current utilization of TM for spine surgery.
11/2/20
Del Riccio M, Lorini C, Bonaccorsi G, et al. | Int J Environ Res Public Health
Aim: To review the association between seasonal influenza vaccination and the risk of SARS-CoV-2 infection or complicated illness or poor outcome (e.g. severe disease, need for hospitalization or ventilatory support, or death) among COVID-19 patients.
UPDATED
11/2/20
Chen J, Wu C, Wang X, et al. | Front Endocrinol
Aim: To summarize available data on the association between glycemic parameters and severity of COVID-19.
11/1/20
Khanlou N, Ssawe A, Vazquez LM, et al.  | CMH Initiative
Aim: To review the evidence on the racialized and gendered social determinants of mental health among women and girls exposed to gender-based violence during the COVID-19 pandemic.
11/1/20
Strudwick G, Sockalingam S, Crawford A, et al.  | CMH Initiative
Aim: To synthesize and mobilize knowledge related to digital interventions that can be leveraged by the general population to support mental health during and after COVID-19.
11/1/20
Larney S, Bruneau J, Raynault MF, et al  | CMH Initiative
Aim: To assess the impacts of "Big Events" like the COVID-19 pandemic on risk behaviors and drug-related harms among people who use drugs and the delivery of harm reducation and drug treatment services.
10/29/20
Patel U, Malik P, Mehta D, et al. | J Glob Health
Aim: To evaluate epidemiological characteristics, needs of resources, outcomes, and global burden of the disease.
10/29/20
Kumar R, Nedungalaparambil NM, Mohanan N | J Family Med Prim Care
Aim: To review the evidence on emergency and primary care collaborations during the COVID-19 pandemic.
10/29/20
PHAC Emerging Science Group | Public Health Agency of Canada
Aim: To review the evidence on whether hosptialized SARS-CoV-2 patients that successfully recover with no subsequently positive RT-PCR tests present with SARS-CoV-2 antibody levels or seropositivity rates differ from those that do retest positive?
10/29/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of fit testing and fit checking for testing the protection of a respirator.
10/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the contributing factors of a second spike in COVID-19 cases.
10/26/20
Mirzaie H, Vahidi M, Shokoohi M, et al. | medRxiv
Aim: To summarize the evidence on COVID-19 patients with HBV or HCV co-infections. 
10/22/20
Perras C, Pohar S, Manoharan A, et al. | CADTH
Aim: To review the current scientific evidence on the potential benefits and harms of remdesivir.
UPDATED
10/21/20
Nguyen VT, Riviere P, Ripoll P, et al. | J Clin Epidemiol
Aim: To describe the planning of randomized controlled trials (RCTs) in terms of timing related to the course of the COVID-19 epidemic and research question evaluated.
10/19/20
 | CADTH
Aim: To review the various strategies being used to increase the availability of N95 masks.
10/19/20
Pluddemann A, Aronson JK | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the role of T cells and antibodies in immunity to COVID-19 infection.
10/16/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on factors that may help protect Indigenous peoples and communities in Canada and internationally from the COVID-19 pandemic and its impacts.
10/15/20
 | NSW Health COVID-19 Critical Intelligence Unit
10/8/20
Gianola S, Jesus TS, Bargeri S, et al. | PLoS One
Aim: To take a snapshot of the amount of scientific development devoted to COVID-19 and gain an idea of the current status of global research. 
10/8/20
Ehaideb SN, Abdullah ML, Abuyssin B, et al. | Crit Care
Aim: To assess whether the newly created models reproduce the full spectrum of human COVID-19.
10/7/20
 | NSW Health COVID-19 Critical Intelligence Unit
10/7/20
Ferner RE, Aronson JK | Oxford COVID-19 Evidence Service
10/7/20
 | NSW Health COVID-19 Critical Intelligence Unit
10/6/20
Sharma SK, Mishra M, Mudgal SK | J Educ Health Promot
Aim: To update the available most recent evidences on efficacy of cloth face masks in prevention of viral infection transmission.
10/6/20
Jena A, Singh AK, Kumar-M P, et al. | Dig Liver Dis
Aim: To identify the frequency and reasons for the disruption of care for IBD patients and attempted to identify regional differences in patterns of adherence to IBD therapies.
10/2/20
Yang S, Li A, Eshaghpour A, et al. | BMJ Evid Based Med
Aim: To review the trends and quality of evidence in early SARS-CoV-2 publications.
9/30/20
Cascini F, Hoxhaj I, Zace D, et al. | Eur J Public Health
Aim: To review the evidence on healthcare system approaches, experiences and recommendations used to manage COVID-19 and other epidemics.
9/29/20
Oliveira LV, Silva C, Lopes LP, et al. | Rev Assoc Med Bras
Aim: To review the current scientific evidence of vertical transmission related to coronavirus disease 2019 (COVID-19).
9/29/20
Bhattacharjee S, Banerjee M | SN Compr Clin Med
Aim: To analyze the clinical profile and outcomes in a total of 45 cases of new-onset ITP in COVID-19 patients described in literature until date.
9/29/20
Abuelgasim E, Dona ACM, Sondh RS, et al. | Dermatol Ther
Aim: To review the current literature on urticaria in COVID-19 patients and to provide insight into urticarial pathogenesis and management in such patients.
9/28/20
Sheleme T, Bekele F, Ayela T | Infect Dis
Aim: To summarize clinical presentations of this newly emerging coronavirus disease.
9/28/20
 | Public Health Agency of Canada
Aim: Not provided
9/28/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the potential for COVID-19 re-infection, including new transmission after recovery.
9/28/20
de Assis GG, Murawksa-Cialowicz E, Cieszczyk P, et wl. | Front Neurol
Aim: To review the evidence on the implications and mechanisms of infections by respiratory CoVs.
9/25/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence that CPR is aerosol generating and current advice for CPR in patients with suspected or confirmed COVID-19.
9/24/20
Berling I, King JD, Shepherd G, et al. | J Am Soc Nephrol
Aim: To determine the effect of and indications for extracorporeal treatments in cases of poisoning with chloroquine, hydroxychloroquine, and quinine.
9/23/20
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the medium-term and long-term health impacts of COVID-19 on infection survivors.
9/22/20
Shield KD, Wells S, Rehm J, et al. | CMH Initiative
Aim: To review the evidence on alcohol consumption during periods of crisis and how the evidence can be applied to alcohol policy recommendations.
9/22/20
van Boekel L, Stoop A, Luijkx KG | Tijdschr Gerontol Geriatr
Aim: To understand what we can learn from previous crises or disasters worldwide to optimize the care for older adults in long term care facilities during the outbreak of COVID-19. 
9/22/20
 | CADTH
Aim: To review evidence related to airflow transmission of SARS-CoV-2 and the risk associated with the use of heating, ventilation, and air conditioning (HVAC) systems.
9/21/20
Singh S, Fong HK, Mercedes BR, et al. | Resuscitation
Aim: To review the evidence on the change in out-of-hospital cardiac arrest indicence and mortality during the COVID-19 outbreak in various countries.
9/21/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on opioid and substance use and related harms.
9/18/20
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the effectiveness of reducing prison populations to reduce the spread of COVID-19.
9/18/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether domestic animals can become infected with and transmit COVID-19.
9/18/20
Lagzian M, Dadkhah M, Mehraeen A | Eur J Clin Invest
Aim: To recognize the challenges policymakers have typically experienced during pandemic diseases, including Covid-19, and, accordingly, new information technology capabilities to encounter with them.
9/17/20
McLane P | Alberta Health Services
Aim: To review the evidence on the factors impacting attitudes toward or adherence to COVID-19 public health guidelines and interventions to create more positive attitudes towards following guidelines.
9/15/20
Cheruiyot I, Henry B, Lippi G, et al. | Acta Biomed
Aim: To assess whether AKI may be associated with worse prognosis and increased mortality in COVID-19 patients
UPDATED
9/15/20
 | Health Information and Quality Authority, Ireland
Aim: To review the evidence on the duration of infectiousness in those that test positive for SARS-CoV-2 RNA.
9/15/20
 | Quebec National Institute of Public Health
Aim: To review the evidence on risk factors for severe infections and potential for transmission in children.
9/15/20
Sharpe H | Alberta Health Services
Aim: To review the evidence on different methods, completion rates, and costs for self-collected samples for SARS-CoV-2 RT-PCR.
9/14/20
Klein MG, Cheng CJ, Lii E, et al. | Disaster Med Public Health Prep
Aim: To highlight models that project both caseload and hospital capacity requirements over time.
9/14/20
Fernandez R, Lord H, Halcomb E, et al. | Int J Nurs Stud
Aim: To synthesize and present the best available evidence on the experiences of nurses working in acute hospital settings during a pandemic.
9/14/20
Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. | J Dent Res
Aim: To provide a comprehensive up-to-date summary of oral manifestations in patients with COVID-19.
9/11/20
Lenferink LIM, Meyerbroker K, Boelen PA | Psychiatry Res
Aim: To review the evidence on online Eye Movement Desensitization and Reprocessing (EMDR) treatment for PTSD.
9/11/20
Abdoul-Azize HT, El Gamil R | Glob Soc Welf
Aim: To explore the current implementation of social protection programs during the COVID-19 pandemic in the most affected countries as well as to provide learned lessons from countries that had not previously considered implementing social protection programs up until the COVID-19 crisis. 
9/11/20
Heidary F, Gharebaghi R | Expert Rev Clin Immunol
Aim: To review the evidence on the antiviral effects of TRIM56.
9/10/20
Housing for Health Project | University of Alberta
Aim: To review the evidence on the built environment factors associated with physical activity among older adults during the acute and recovery phases of the COVID-19 and future pandemics.
9/10/20
Tricco A | Drug Safety and Effectiveness Network
Aim: To review the evidence on the safety and effectiveness of using fractional dosing strategies to deliver intramuscular seasonal influenza vaccines.
9/10/20
Cyr G, Gabet M | Centre de Recherche en Sante Publique
Aim: To review the evidence on the best practices for managing a regional coordination center in a crisis situation.
9/10/20
Lester S, Khatwa M, Sutcliffe K | JAMA Intern Med
Aim: To gain a deeper understanding of the kinds of services that young people exposed to ACEs feel they need.
9/10/20
Major R, Selvaskandan H, Makkeyah YM, et al. | J Am Soc Nephrol
Aim:  To assess the CKD-related inclusion and exclusion criteria for COVID-19 trials.
9/10/20
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the long-term impacts of COVID-19 on infection survivors.
9/3/20
Martin A, Blom IM, Whyatt G, et al. | Disaster Med Public Health Prep
Aim: To explore the involvement of medical students in past global health emergencies, to help inform current and future scenarios.
UPDATED
9/3/20
Sergeant A, van Reekum EA, Sanger N, et al. | BMJ Open
Aim: To study the effect of pandemics and epidemics on mental health outcomes for people with premorbid mental disorders.
UPDATED
9/3/20
 | Health Information and Quality Authority, Ireland
Aim: To review guidance for residential care facilities in the context of COVID-19.
9/3/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the risk of adverse maternal or fetal outcomes in women diagnosed with COVID-19 during pregnancy.
9/3/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the volume-outcome relationship for surgical interventions.
9/1/20
Gomez-Ochoa SA, Franco OH, Rojas LZ, et al. | Am J Epidemiol
Aim: To systematically review the evidence on the prevalence, risk factors, clinical characteristics, and prognosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among HCW.
9/1/20
Leal J, Gagnon H | Alberta Health Services
Aim: To review the evidence on transmission of COVID-19 in condos, apartments, and/or hotels.
9/1/20
Gagnon MP | Universite Laval
Aim: To review the evidence on effective digital health interventions to prevent, detect, and manage mental health problems in individuals with a pre-existing chronic diseases.
9/1/20
Sharpe H | Alberta Health Services
Aim: To review the evidence on the harm of mask use in specific patient populations.
9/1/20
Allison P, de Souza RF, Aboud L, et al. | Public Health Agency of Canada
Aim: To review the evidence on safe dental practices during the COVID-19 pandemic.
9/1/20
Clements F | University of Calgary, Health Technology Assessment Unit
Aim: To review the evidence on the immunogenicity and safety of the influenza vaccine at reduced or regular intradermal doses compared with a full intramuscular dose.
9/1/20
Smale J | Timiskamig Health Unit
Aim: To review the harms being experienced by community dwelling low income populations from staying at home for long periods of time during current or past pandemics.
9/1/20
Erdmann R | Alberta Health Services
Aim: To review the evidence on the risk factors associated with the development of severe outcomes in COVID-19.
9/1/20
Carroll A, Hicks A, Saxinger L, et al. | Alberta Health Services
Aim: To review the evidence on the role of children in community SARS-CoV-2 transmission.
8/31/20
Juni P, Maltsev A, Bobos P, et al. | Ontario COVID-19 Science Advisory Table
Aim: What is the role of children in SARS-CoV-2 transmission?
8/31/20
Centeno-Tablante E, Medina-Rivera M, Finkelstein J, et al. | Ann N Y Acad Sci
Aim: To capture information that might necessitate changes in the guidance on breast milk and breastfeeding given the uncertainty in this area.
8/26/20
Kumar D, Loshak H | CADTH
Aim: To compare hand washing with soap and water to hand sanitation solutions, and to review handwashing guidelines for health care workers that come in contact with patients.
8/26/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the medium- and long-term health sequelae of COVID-19 infection among survivors.
8/26/20
Kotwal A, Yadav A, Kotwal J | Med J Armed Forces India
Aim: To assess correlation between predicted and actual values of cases in India.
8/26/20
Nieto I, Navas JF, Vazquez C | Brain Behav Immun Health
Aim: To examine compliance with basic methodological quality criteria and open scientific research practices on the mental health effects of the COVID-19 pandemic.
8/22/20
Bayona HHG, Cabaluna ITG, Dans AP, et al. | Asia Pacific Center for Evidence Based Healthcare
Aim: To summarize the available evidence on the diagnostic accurancy of rapid antigen tests for COVID-19.
8/21/20
Lechien JR, Radulesco T, Calvo-Henriquez C, et al. | Head Neck Pathol
Aim: To review the data regarding the expression of angiotensin converting enzyme-2 (ACE2) and transmembrane protease serine-2 (TMPRSS2) in head and neck tissue.
8/21/20
 | Health Information and Quality Authority, Ireland
Aim: To review the evidence on the routine wearing of face masks by healthy persons in the community in reducing the transmission of respiratory pathogens.
8/20/20
 | Public Health Agency of Canada
Aim: Not provided
8/19/20
Selman L, Lapwood S, Jones N, et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on advance care planning in community settings during the COVID-19 pandemic.
8/19/20
Remillard L, Perras C, Pant S, et al. | CADTH
Aim: To review the current scientific evidence on the potential benefits and harms of chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19. 
8/19/20
 | Public Health Agency of Canada
8/19/20
 | Public Health Agency of Canada
Aim: To review the evidence on the difference in risk of transmission from persons who are pre- and asymptomatic infected cases compared to symptomatic cases?
8/19/20
 | Public Health Agency of Canada
Aim: To examine the evidence on whether pregnant women at higher risk of severe COVID-19 disease than non-pregnant women of reproductive age.
8/19/20
 | Public Health Agency of Canada
Aim: To review the evidence on the impact of physical distancing of 1 meter, 1.5 meters and 2 meters on SARS-CoV-2 virus transmission risk.
8/19/20
 | Public Health Agency of Canada
8/19/20
Kumar D, Spry C | CADTH
Aim: To review the evidence on the effectiveness of face shields at preventing SARS-CoV-2 virus transmission.
8/19/20
Guentcheva I | Centre de Recherche en Sante Publique
Aim: To review the effectiveness of the obligation to wear a mask in a population without concrete social acceptability measures having been deployed beforehand.
8/19/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of wearing a surgical mask at the same time as an oxygen mask.
8/19/20
Topfer L | CADTH
Aim: To identify a list of potential technologies that may be used to address the negative effects of social isolation on older adults living in long-term care.
8/14/20
Manchanda ECC, Sanky C, Appel JM | J Racial Ethn Health Disparities
Aim: To identify and review all publicly available state-level CSC in the USA and to compare the ways in which CSC prioritize patients for the allocation of scarce resources such as ventilators, and to consider the ethical and equity implications of these decisions.
8/12/20
Watts T, Choi Y, Odutayo A, et al. | Ontario COVID-19 Science Advisory Table
Aim: To review the evidence on the decrease in antibodies against SARS-CoV-2 over time.
8/12/20
Juni P, Odutayo A, Allen U, et al. | Ontario COVID-19 Science Advisory Table
Aim: To review the evidence on the use of dexamethasone in patients hospitalized for COVID-19.
8/11/20
Jones L, Candy B, Roberts N, Ondruskova T, et al | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the management of delirium in patients with COVID-19 and the use of non-pharmacological approaches outside of critical care settings.
UPDATED
8/11/20
Chen C, Pan K, Wu B, et al. | Eur J Clin Pharmacol
Aim: To evaluate the safety of HCQ in the treatment of COVID-19 and other diseases by performing a systematic review and meta-analysis.
8/11/20
Licina A, Silvers A, Stuart RL  | Syst Rev
Aim: To evaluate the effect of powered air-purifying respirators (PAPRs) as part of respiratory protection versus another device (egN95/FFP2) on HCW infection rates and contamination.
UPDATED
8/6/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the extended use or re-use of personal protective equipment (PPE) during COVID-19.
UPDATED
8/6/20
Tariq R, Saha S, Furqan F, et al. | Mayo Clin Proc
Aim: To evaluate the prevalence of gastrointestinal (GI) symptoms and mortality in patients with coronavirus disease 2019 (COVID-19) diagnosed.
8/6/20
Agyeman AA, Chin KL, Landersdorfer CB, et al. | Mayo Clin Proc
Aim: To estimate the prevalence of olfactory and gustatory dysfunctions (OGDs) among patients infected with novel coronavirus disease 2019 (COVID-19).
8/5/20
Kariyanna PT, Sutarjono B, Grewal E, et al. | Am J Med Case Rep
Aim: To identify the clinical features of myocarditis in COVID-19 patients.
8/5/20
Pei L, Zhang S, Huang L, et al. | Pol Arch Intern Med
Aim: To evaluate the impact of drug therapy on the risk of death in patients with COVID-19.
8/5/20
 | Public Health Agency of Canada
Aim: To review the evidence for age-dependent transmission of SARS-CoV-2.
8/5/20
Kumar A, Arora A, Sharma P, et al. | Indian J Gastroenterol
Aim: To determine the frequency of GI and hepatic manifestations of COVID-19 and to explore their relationship with severe clinical course.
UPDATED
8/5/20
Ghahramani S, Tabrizi R, Lankarani KB, et al. | Eur J Med Res
Aim: To understand the common laboratory features of COVID-19 in severe cases versus non-severe patients could be quite useful for clinicians and might help to predict the model of disease progression.
UPDATED
8/5/20
Reddy RK, Charles WN, Sklavounos A, et al. | J Med Virol
Aim: To rigorously and definitively quantify the effects of smoking on COVID-19 severity.
UPDATED
8/5/20
Mansourabadi AH, Sadeghalvad M, Mohammadi-Motlagh H, et al. | Life Sci
Aim: To describe the role of the immune system in response to COVID-19.
8/5/20
Desiato VM, Levy DA, Byun YJ, et al. | Am J Rhinol Allergy
Aim: To perform a systematic review and meta-analysis of the prevalence of OD in the healthy general population, review the various assessment metrics used, and compare pooled OD prevalence rates.
8/5/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the symptoms and incidence for vascular events in patients with COVID-19.
8/5/20
Hasan SS, Radford S, Kow CS, et al. | J Thromb Thrombolysis
Aim: To systematically review the available evidence to help guide clinicians weighing up decisions regarding the anticoagulation approach for COVID-19 patients admitted to intensive care units.
8/4/20
Gao Y, Ye L, Zhang J, et al. | BMC Infect Dis
Aim: To systematically review the clinical features and outcomes of pregnant women with COVID-19.
UPDATED
8/4/20
Yoon SH, Kang J, Ahn JG | Eur Rev Med Pharmacol Sci
Aim: To evaluate the clinical manifestations and outcomes of neonates born to women who had Coronavirus Disease 2019 (COVID-19) during pregnancy.
8/4/20
Kay JK, Parsel SM, Marsh JJ, et al. | JAMA Otolaryngol Head Neck Surg
Aim: To review evidence on the risks of aerosolization and transmission of SARS-CoV-2 from patients to health care personnel during endoscopy of the upper aerodigestive tract.
8/4/20
Elgohary G | Hematol Oncol Stem Cell Ther
Aim: To evaluate the impact of COVID-19 infection on cancer patients. 
8/4/20
Khan S, Gionfriddo MR, Cortes-Penfield N, et al. | Expert Opin Pharmacother
Aim: To synthesize the literature on COVID-19 pharmacotherapy to inform practice and policymaking.
8/2/20
Sahu AK, Amrithanand VT, Mathew R, et al. | Am J Emerg Med
Aim: To determine the proportion of HCW who were COVID-19 positive among all the COVID-19 patients. 
8/2/20
Harrop E, Mann M, Semedo L, et al. | Palliat Med
Aim: To synthesise the evidence regarding system-level responses to mass bereavement events, including natural and human-made disasters as well as pandemics, to inform service provision and policy during the COVID-19 pandemic and beyond.
7/31/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how long the virus can survive with potential for infection on surfaces.
UPDATED
7/31/20
Mitchell S, Maynard V, Lyons V, et al | Palliat Med
Aim: To synthesise existing evidence related to the delivery of palliative and end-of-life care by primary healthcare professionals in epidemics and pandemics.
UPDATED
7/30/20
Hadeler E, Gitlow H, Nouri K | Arch Dermatol Res
Aim: To evaluate recent studies that have analyzed patient satisfaction with teledermatology. 
7/29/20
Chakravarti A, Upadhyay S, Bharara T, et al. | Indian J Med Microbiol
Aim: To provide an insight about the current understanding, knowledge gaps and a perspective on the future of coronavirus disease 2019 (COVID-19) infections. 
7/29/20
Shulte PA, Streit JMK, Sheriff F, et al. | Ann Work Expo Health
Aim: To identify and characterize scenarios and hazards in the future of work after a global pandemic.
7/24/20
PHAC Emerging Science Group, Public Health Agency of Canada  | Public Health Agency of Canada
Aim: To review the evidence on the effectiveness of face shields at preventing SARS-CoV-2 virus transmission, with and without additional mask wearing.
7/24/20
PHAC Emerging Science Group, Public Health Agency of Canada  | Public Health Agency of Canada
Aim: To review the evidence on the aerodynamic properties of SARS-CoV-2 virus and travel distance, and the implications on transmission risk.
7/24/20
 | Sante Publique France
7/24/20
 | Sante Publique France
7/23/20
James HK, Pattison GTR | J Surg Educ
Aim: To synthesise the current evidence of pandemic-related impact on surgical training internationally and describe strategies that have been put in place to mitigate disruption.
7/23/20
 | Public Health Agency of Canada
Aim: To review the evidence on determinants of individual adherence to public health interventions to prevent COVID-19.
7/22/20
PHAC Emerging Science Group, Public Health Agency of Canada  | Public Health Agency of Canada
Aim: To review the evidence on the de-escelation of "household bubbles" during the COVID-19 pandemic.
7/22/20
PHAC Emerging Science Group, Public Health Agency of Canada  | Public Health Agency of Canada
Aim: To review the evidence on the thresholds or allowable sizes of gatherings or events during the COVID-19 pandemic.
7/22/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the impact of the COVID-19 pandemic on families with children.
7/22/20
Bertrand K, Camire M, Milot D, et al. | University of Sherbrooke
Aim: To review the evidence on gender and sexual diversity in the adaptation of services in the context of the COVID-19 pandemic.
7/20/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the efficacy of face masks in helping to prevent the spread of COVID-19.
UPDATED
7/20/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk of adverse post-operative outcomes on patients with COVID-19 or who have previously had COVID-19.
7/20/20
Eichberg DG, Basil GW, Di L, et al. | Neurosurgery
Aim: To conduct a systematic literature review investigating treatment of neurosurgical patients via telemedicine, and to evaluate barriers and challenges.
7/18/20
Verdugo-Paiva F, Izcovich A, Ragusa M, et al. | Medwave
Aim: To provide a timely, rigorous, and continuously updated summary of the evidence on the role of lopinavir/ritonavir in the treatment of patients with COVID-19.
UPDATED
7/17/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether cardiac stress testing is an aerosol generating procedure and its risk to healthcare workers.
7/17/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-surgery innovations in an outpatient setting, such as virtual follow up and rehabilitation, in improving outcomes for patients who have undergone surgery.
7/16/20
Garg PK, Kaul P, Choudary D, et al. | J Surg Oncol
Aim: To systematically evaluate the available literature on the impact of COVID-19 on cancer care and to critically analyze the diagnostic and therapeutic strategies suggested by various healthcare providers, societies, and institutions. 
7/16/20
Blair B | Simcoe Muskoka District Health Unit
Aim: To review the evidence on whether staying at home for long periods of time during current or past pandemics worsens the rates of mental and social health outcomes.
7/14/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the resumption of elective surgery following cancellation and deferment of routine services during COVID-19.
7/14/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on low-value surgery and how to reduce it.
7/14/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on post-surgery innovations in hospital such as enhanced recovery, early mobilisation and early discharge in improving outcomes for patients who have undergone surgery?
7/14/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on ways to increase productivity or efficiency in operating theatres and managing elective surgery waiting lists?
7/14/20
Gavriilidis P, Pai M | J Clin Med Res
Aim: To summarise the existing evidence of impact of COVID-19 global pandemic on liver transplant recipients.
7/10/20
 | Public Health Agency of Canada
Aim: To review the evidence on the risk of SARS-CoV-2 virus transmission from singing or playing a wood instrument in a choir, orchestra and/or practice setting with other people.
7/10/20
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the impacts of COVID-19 mitigation on non-COVID-19 populations with pre-existing mental health conditions.
7/10/20
Lewis J, Mackey K | VA Evidence Synthesis Program
Aim: To critically appraise the identified study and provide additional context for study findings.
VA ESP
7/10/20
Kernohan A, Calderon M | Oxford COVID-19 Evidence Service
Aim: To review the evidence on risk factors or management of VTE.
UPDATED
7/9/20
Mackey S, Warren C | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the impacts of COVID-19 mitigation on non-COVID-19 populations with pre-existing substance use and addictions issues.
7/8/20
 | Sante Publique France
7/8/20
Ravani P, Saxinger L, Chandran U, et al. | Alberta Health Services
Aim: To evaluate the current prevalence of COVID-19 infection among asymptomatic patients presenting to Emergency Rooms and requiring hospital admission.
7/8/20
 | Sante Publique France
7/7/20
Lin Y, Duan Q, Zhou Y, et al. | Front Med
Aim: To review existing mathematical and statistical models and build a mathematical model to estimate the transmission capacity, epidemiological characteristics, potential peak time and size, and elimination time of COVID-19.
7/6/20
Laperriere H, Bendevis C, et al. | CIHR IRSC
Aim: To review the evidence on how COVID-19 is affecting the mental health of indigenous community members in Ottawa-Gatineau who are living with or affected by HIV or related issues.
7/6/20
Kania-Richmond A, Saxinger L, Manns B | Alberta Health Services
Aim: To review the evidence for the effectiveness of remdesivir as a treatment for COVID-19.
7/3/20
Spencer EA, Brassey J, Jefferson T, et al. | Oxford COVID-19 Evidence Service
Aim: To explore if climate conditions may influence the spread of SARS-CoV-2.
UPDATED
7/3/20
Pranata R, Permana H, Huang I, et al. | Diabetes Metab Syndr
Aim: To investigate the association between use of angiotensin-converting enzyme inhibitor (ACEI)/angiotensin-receptor blocker (ARB) and outcomes of hypertensive COVID-19 patients.
7/1/20
Greaves L, Brabete AC, Wolfson L, et al. | Centre of Excellence for Women's Health
Aim: To review the evidence on the role of natural disasters and pandemics in intimate partner violence among women and the role of substance use in intimate partner violence among women.
6/30/20
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the best practices for personal care workers providing home care in the context of COVID-19.
6/30/20
Beesoon S, Jelinski S | Alberta Health Services
Aim: To review the evidence on the risks of infection transmission related to aerosol generation through dental procedures.
6/29/20
Dube L, Paquet C, Cisneros-Franco M, et al. | McGill University
Aim: To identify and examine the effectiveness of social connectedness interventions at reducing feelings of social isolation and loneliness and promoting wellbeing, resilience, and coping in the context of infection control-related social and physical distancing measures.
6/26/20
Hanrahan JG, Burford C, Adegboyega G, et al. | World Neurosurg
Aim: To detail early experiences and changes to neurosurgical practice in response to the COVID-19 pandemic.
6/26/20
Helfand M | VA Evidence Synthesis Program
Aim: To review the evidence for using corticosteroids to treat acute respiratory distress syndrome in patients with COVID-19.
VA ESP
6/26/20
Duan-Porter W | VA Evidence Synthesis Program
Aim: To explore the length of stay in the intensive care unit (ICU) and time on invasive mechanical ventilation for adult patients with COVID-19.
UPDATED
VA ESP
6/26/20
 | Health Information and Quality Authority, Ireland
Aim: To review guidance on physical distancing in non-healthcare settings.
6/25/20
 | ECRI
Aim: To provide guidance on ways to protect staff, measures to limit transmission, recommendations for COVID-19 testing for pregnant women and for infants born to infected mothers, and optimal maternal care and breastfeeding recommendations.
6/25/20
Saleem H, Rahman J, Aslam N, et al. | Cureus
Aim: To review the evidence on COVID-19 severity in children.
6/25/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk of acquiring COVID-19 on an aircraft.
6/25/20
Pelland-St-Pierre L, Duquesne L | Center for Research in Public Health
Aim: To review the evidence on COVID-19 outbreaks in childcare centers and schools, including risk factors, symptoms, and attack rates.
6/25/20
Pelland-St-Pierre L, Duquesne L | Centre de Recherche en Sante Publique
Aim: To review the evidence on outbreaks of COVID-19 infection in childcare services and schools across the world.
6/25/20
Espinosa OA, Dos Santos Zanetti A, Antunes EF, et al. | Rev Inst Med Trop Sao Paulo
Aim: To calculate the prevalence and geographical distribution of comorbidities in all patients admitted to intensive care units (ICUs), and the mortality rate of COVID-19.
6/25/20
Qureshi Z, Jones N, et al. | Oxford COVID-19 Evidence Service
Aim: To identify the evidence behind the 2-metre social distancing rule in the context of the still used large vs. small (droplet vs airborne) droplet size dichotomy in route of transmission.
UPDATED
6/24/20
Gordon M, Kagalwala T, Rezk K, et al. | BMJ Paediatr Open
Aim: To carry out a systematic review of the available studies on COVID-19 (coronavirus disease 2019) in neonates seen globally since the onset of the COVID-19 global pandemic in 2020.
6/24/20
Xu L, Mao Y, Chen G, et al. | Aging
Aim: To systematically review evidence for the risk factors of COVID-19 patients progressing to critical illness.
6/24/20
Jones P, Roberts S, Hotu C, et al. | Emerg Med Australas
Aim: To determine the carriage of respiratory viruses on facemasks used by HCW.
6/23/20
Gao Y, Liu R, Zhou Q, et al. | Ann Transl Med
Aim: To assess the effectiveness of telemedicine in reducing transmission of COVID-19 and reducing pressure on medical institutions.
UPDATED
6/23/20
Yang N, Che S, Zhang J, et al. | Ann Transl Med
Aim: To conduct a rapid review of mother-to-child transmission of COVID-19 during breastfeeding.
UPDATED
6/23/20
Ofori-Asenso R, Ogundipe O, Agyeman AA, et al. | Ecancermedicalscience
Aim: To examine the prevalence of cancer and its association with disease severity in patients with novel coronavirus disease 2019 (COVID-19).
6/23/20
Gold MS, Sehayek D, Gabrielli S, et al. | Postgrad Med
Aim: To evaluate comorbidities associated with severe and fatal cases of COVID-19.
6/23/20
Montesanti S, Silverstone P, Wells L, et al. | CIHR IRSC
Aim: To specifically understand the potential of trauma-focused virtual interventions that can rapidly be used to support domestic violence and sexual assault populations.
6/23/20
Zhou Q, Gao Y, Wang X, et al. | Ann Transl Med
Aim: To understand nosocomial infection in patients with COVID-19, SARS, and MERS.
UPDATED
6/23/20
Thulien N, Noble A, Daley M, et al. | CIHR IRSC
Aim: To review the evidence on promising mental health and substance use practices utilized by front-line providers serving young people who are experiencing or have experienced homelessness during the COVID-19 pandemic.
6/23/20
Li W, Liao J, Li Q, et al. | Ann Transl Med
Aim: To review the evidence on how health providers should advise families and parents to obtain health education information during the COVID-19 pandemic.
6/23/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the effect of the COVID-19 pandemic on alcohol use and alcohol-related harms.
6/23/20
Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, Kumar S, Bhattacharyya A, Kumar H, Bansal S, Medhi B | Indian J Pharmacol
Aim: To review the structural basis of different target proteins of SARS-corona virus (CoV2) from a viral life cycle and from drug design perspective.
6/22/20
Goodarzi Z, Watt J, Kirkham J, et al | CIHR IRSC
Aim: To review the evidence on the effect of telehealth interventions on depression or depressive symptoms in older adults.
UPDATED
6/22/20
Best MW, Grossman M, Bowie C, et al. | TIP Research Lab
Aim: To review the evidence on interventions for schizophrenia-spectrum disorders for virtual delivery.
6/22/20
Lam R, Murphy J, Michalak E, et al. | CIHR IRSC
Aim: To review the evidence on at-risk groups and their mental health needs in the context of COVID-19 in the Asia Pacific Region and recommendations for improving access to digital mental health support.
6/22/20
Lee V, Albaum C, Modica PT, et al. | CMH Initiative
Aim: To better understand what has been documented regarding the impact of the COVID-19 pandemic on caregiver and family functioning, and on mental health services response.
6/22/20
Karanasos A, Aznaouridis K, Latsios G, et al. | Nicotine Tob Res
Aim: To summarize relevant studies and quantify the impact of smoking on disease severity and mortality of hospitalized COVID-19 patients.
6/22/20
Armitage LC, Brettel R | Oxford COVID-19 Evidence Service
Aim: To review the current evidence on the use of inhaled corticosteroids to prevent the development of acute respiratory distress syndrome.
6/22/20
Carroll S, Collins B, Dolce M, et al. | CIHR IRSC
Aim: To review the evidence on how to prevent or mitigate mental health and substance use responses for those at risk of severe COVID-19 infection.
6/22/20
Birnie KA, Noel M, Stinson J, et al. | CIHR IRSC
Aim: To review the evidence on virtual care solutions for pain, mental health, and substance use in youth with pre-existing and new onset pain actross the stepped care model during the COVID-19 pandemic.
6/21/20
Parohan M, Yaghoubi S, Seraji A | Eur Heart J Acute Cardiovasc Care
Aim: To summarize available findings on the association between cardiac injury and severity of COVID-19 infection.
6/21/20
Kunustor SK, Laukkanen JA | J Infect
Aim: To review the evidence on the characteristics and prevalence of hepatic manifestations and complications of COVID-19
6/21/20
Ghannam MG, Alshaer QA, Al-Chalabi MAC, et al. | J Neurol
Aim: To clarify the neurological complications of SARS-CoV-2 infection including the potential mechanisms and therapeutic options.
UPDATED
6/21/20
Montana M, Montero V, Khoumeri O, et al. | Molecules
Aim: To compile and discuss recently published studies concerning the therapeutic potential of the antiviral activity of quinoxaline derivatives.
6/21/20
Bienvenu A, Marty AM, Jones MK, et al. | One Health
Aim: To analyze studies registered on ClinicalTrials.gov that study hydroxycholorquine as a COVID-19 prophylaxis.
6/20/20
Castro-Rodriguez JA, Forno E | Pediatr Pulmonol
Aim: To review the evidence on the role of asthma in children with COVID-19 and the risk of infection.
UPDATED
6/20/20
Nobar NN, Goodarzi A | Dermatol Ther
Aim: To review the evidence on the course of COVID-19 in patients with dermatologic disorders, and the most effective management strategies.
6/20/20
 | Health Technology, Wales
Aim: To reivew the evidence on the use of point-of-care ultrasound imaging for suspected and confirmed cases of COVID-19.
6/20/20
Waller JV, Allen IE, Lin KK, et al. | Invest Radiol
Aim: To stratify studies as high or low risk of bias to determine the true sensitivity of CT for severe acute respiratory syndrome coronavirus-2 infection
6/20/20
Piscitello GM, Kapania EM, Miller WD, et al. | JAMA Netw Open
Aim: To evaluate the number of publicly available US state guidelines for ventilator allocation and the variation in state recommendations for how ventilator allocation decisions should occur and to assess whether unique criteria exist for pediatric patients.
6/19/20
Prato AP, Conforti A, Almstrom M, et al. | Front Pediatr
Aim: To propose technical strategies to assist the pediatric surgeons to minimize the potential aerosolization of viral particles in COVID-19 patients undergoing urgent or emergent surgical treatment using laparoscopic approaches, based on the currently available literature.
6/19/20
Althobaiti S, Alharthi S, Moosa A, et al. | Int J Qual Res
Aim: To review the studies on patient perceptions of nursing care quality.
6/19/20
Asadi L | Alberta Health Services
Aim: To review the evidence on the effectiveness of wearing medical masks, including home-made masks, to reduce the spread of COVID-19 in the community.
6/19/20
Lakhani HV, Pillai SS, Zehra M, et al. | Int J Environ Res Public Health
Aim: To provide insight on the pathogenesis and the transmission dynamics of CoVID-19 along with pharmacological and non-pharmacological intervention strategies to mitigate the clinical manifestation of this virus.
6/19/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the impact of COVID-19 on the mode and content of clinical education and current recommendations to address the impact.
6/19/20
Gkiouras K, Nigdelis MP, Grammatikopoulou MG, et al. | Eur J Clin Invest
Aim: To assess the availability of open data and metrics and of articles pertaining to the COVID?19 outbreak in five high?impact journals.
6/18/20
 | Health Information and Quality Authority, Ireland
Aim: To review the evidence on the pathways for the resumption of scheduled hospital-based care postponed or cancelled due to mitigation measures implemented in response to COVID-19.
6/18/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the safe use of pools for hydrotherapy or aquatic physiotherapy during COVID-19.
6/18/20
Tabari P, Amini M, Moghadami M, et al. | Iran J Med Sci
Aim: To determine countries’ public responses to the epidemic of COVID-19 and how they developed administrative approaches towards the outbreak.
UPDATED
6/17/20
Grover A, Oberoi M | Eur Heart J Cardiovasc Pharmacother
Aim: To review the evidence on the continued use of angiotensin converting enzyme inhibitors (ACEI) and angtiotensin receptor blockers (ARBs) in patients with COVID-19.
UPDATED
6/17/20
Agarwal A, Basmaji J, Muttalib F, et al. | Can J Anaesth
Aim: To describe the efficacy and safety of HFNC in acute hypoxemic respiratory failure; and to determine the risk of dispersion, aerosol generation and associated transmission of COVID-19 with HFNC.
UPDATED
WHO COLLABORATIVE
6/17/20
Sharpe H | Alberta Health Services
Aim: To review the evidence on the safety and efficacy of video laryngoscopy in intubating patients with suspected or confirmed COVID-19.
6/17/20
Galang RR, Chang K, Strid P, et al. | Obstet Gynecol
Aim: To summarize the clinical presentation, course of illness, and pregnancy and neonatal outcomes in pregnant women with MERS-CoV, SARS-CoV, or SARS-CoV-2.
6/17/20
Lauvrak V, Juvet L | Norwegian Institute of Public Health
Aim: To identify any reported associations between increased severity of COVID-19 disease, and infection rates in populations postulated to be socially or economic vulnerable.
6/15/20
Pavan N, Crestani A, Abrate A, et al. | Eur Urol Focus
Aim: To evaluate the risk of virus spread due to surgical smoke during surgical procedures.
6/15/20
Bornstein S | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the psychological impact of self-isolation on older adults living in the community.
6/14/20
Heldwein FL, Loeb S, Wroclawski ML, et al. | Eur Urol Focus
Aim: To summarize guidelines and recommendations on the urology standard of care during the COVID-19 pandemic.
6/14/20
Bonilla-Aldana DK, Cardona-Trujillo MC, García-Barco A, et al. | Infez Med
Aim: To review the evidence on the role of animals as potential reservoirs for MERS-CoV and SARS-CoV.
UPDATED
6/14/20
Samidoust P, Samidoust A, Samadani AA, et al. | Infez Med
Aim: To investigate the incidence of liver injury among published literature from 2019-Jan-01 to 2020-April-03 to provide an outline for further studies on the liver injury of COVID-19. 
6/13/20
Walker KF, O'Donoghue K, Grace N, et al. | BJOG
Aim: To estimate the risk of the neonate becoming infected with SARS-COV-2 by mode of delivery, type of infant feeding and mother-infant interaction. 
6/13/20
Patel NA | Am J Otolaryngol
Aim: To elucidate a better understanding of the global impact of COVID-19 on the pediatric population.
6/12/20
 | Public Health Agency of Canada
Aim: To summarize the literature on associations of ethnicity with risk of infection, severity and mortality to COVID-19.
6/12/20
 | Public Health Agency of Canada
Aim: To review the evidence on characteristics of the workplace that can increase the risk of COVID-19 transmission.
6/12/20
Erdmann R | Alberta Health Services
Aim: To review the evidence on the effectivness of workplace screening programs for reducing the spread of COVID-19 in healthcare settings.
6/12/20
 | National Collaborating Centre for Methods and Tools
Aim: To identify, appraise, and summarize emerging research evidence on the efficacy and cost-effectiveness of copper materials to reduce transmission of the virus.
6/12/20
 | National Collaborating Centre for Methods and Tools
Aim: To identify, appraise, and summarize emerging research evidence on the effectiveness of cohorting virus-positive residents to shared rooms in care facilities.
6/12/20
Chiesa-Estomba CM, Lechien JR, Calvo-Henriquez C, et al. | Oral Oncol
Aim: To summarize in a systematic way the available recommendations from 18 guidelines from all over the world.
UPDATED
6/12/20
 | Malaysian Health Technology Assessment Section
Aim: To provide scientific evidence on the use of XPEL® RX silver ion protection film for COVID-19 based on a request from the Medical Care Quality Section (MOH) following a proposal from a company to introduce the technology.
6/11/20
 | Public Health Agency of Canada
Aim: To review the evidence on SARS-CoV-2 transmission in dental settings, and the infection transmission risk from aerosol generating procedures use in dental care?
6/11/20
Bresee L, MacDougall D | CADTH
Aim: To describe the epidemiology of venous thromboembolism (VTE), review the evidence on the use of pharmacologic thromboprophylaxis for the prevention of VTE, and list ongoing trials.
6/10/20
Bhaumik S, Moola S, Tyagi J, et al. | BMJ Glob Health
Aim: To examine the evidence to inform the potential role, enablers and barriers for community health workers during COVID-19 prevention and control from the National Health Systems Resource Centre (NHSRC), India.
6/10/20
 | ECRI
Aim: To review the evidence on the optimal timing for performing tracheotomy in patients with acute respiratory failure.
6/10/20
Iversen BG, Vestrheim DF, Flottorp S, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the use of face masks by people in the community to reduce the spread of COVID-19.
6/10/20
Pelland-St-Pierre L, Cortes JB | Center for Research in Public Health
Aim: To review the evidence on the impact of contact time, distance between contacts, and the environment on the probablity of transmission of the coronavirus between humans.
6/10/20
Waddell K, Wilson MG, Bullock HL, et al. | McMaster University Health Forum
Aim: To review the evidence on pandemic-related mental health and addictions issues have emerged and what indicators and strategies can be used to monitor and address them.
6/9/20
 | Health Information and Quality Authority, Ireland
Aim: To review the international evidence on immunity and the spread of the virus by children.
UPDATED
6/9/20
Ashcroft J, Byrne MHV, Brennan PA, et al. | Postgrad Med J
Aim: To identify pandemic and disaster medicine-themed training programmes aimed at medical students and to assess whether these interventions had an effect on objective measures of disaster preparedness and clinical outcomes.
6/9/20
Huntley BJF, Huntley ES, Di Mascio D, et al. | Obstet Gynecol
Aim: To ascertain the frequency of maternal and neonatal complications, as well as maternal disease severity, in pregnancies affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
UPDATED
6/8/20
Carver C, Jones N | Oxford COVID-19 Evidence Service
Aim: To determine if there are any known risk factors for ARDS in this infection and whether there are any interventions to prevent ARDS developing.
6/8/20
Parohan M, Yaghoubi S, Seraj A, et al. | Aging Male
Aim: To summarize available findings on the association between age, gender, comorbidities and risk of death from COVID-19 infection.
UPDATED
6/8/20
Williams S | Newfoundland and Laborador Centre for Applied Health Research
6/7/20
Kunutsor S, Laukkanen | J Infect
Aim: To review the evidence on cardiovascular complications associated with COVID-19.
UPDATED
6/7/20
Dedeilia A, Sotiropoulos MG, Hanrahan JG, et al. | In Vivo
Aim: To identify the challenges imposed on medical and surgical education by the COVID-19 pandemic, and the proposed innovations enabling the continuation of medical student and resident training. 
6/6/20
Alimohamadi Y, Taghdir M, Sepandi M | J Prev Med Public Health
Aim: To estimate the pooled R0 for COVID-19 in the current outbreak.
6/6/20
Quah P, Li A, Phua J | Crit Care
Aim: To review the outcomes of ICU patients with COVID-19 from the existing literature.
6/5/20
Lahiri A, Jha SS, Bhattacharya S, et al. | Indian J Public Health
Aim: To understand the effectiveness of NPIs reported in the contemporary literatures describing prediction models for prevention of the ongoing pandemic of SARS-CoV-2 specifically in Indian population.
6/5/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the transmission of COVID-19 to and from healthcare professionals and strategies to reduce risk of nosocomial infections of COVID-19.
6/5/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on isolation periods other than 14 days in response to COVID-19 in various jurisdictions.
6/5/20
Leal J | Alberta Health Services
Aim: To review the evidence on the transmission of SARS-CoV-2 virus through heating, ventiliation, and air conditioning (HVAC) systems in hospitals or non-hospital settings.
6/5/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the duration from expsoure to symptoms or diagnosis for COVID-19.
6/5/20
Mackey S, Warren C, Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the approaches being taken to mitigate the risks associated with reopening establishments that provide personal services.
6/5/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence regarding temporary workforce reconfigurations such as splitting of teams and establishing social distancing protocols within teams to minimise staff exposure to COVID-19.
UPDATED
6/4/20
Rosenwohl-Mack A, Schumacher K, Fang ML, et al. | Int J Nurs Stud
Aim: To synthesize the evidence on experiences of aging in place in the United States.
6/4/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of computed tomography in patients with COVID-19.
6/4/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the infection rate, infectivity and transmission of COVID-19 in children?
6/4/20
Byambasuren O, Cardona M, Bell K, et al. | medRxiv
Aim: To synthesize all available research on the asymptomatic rates and transmission rates where possible. 
6/4/20
Pranata R, Lim MA, Huang I, et al. | J Renin Angiotensin Aldosterone Syst
Aim: To investigate the association between hypertension and outcome in patients with Coronavirus Disease 2019 (COVID-19) pneumonia.
6/4/20
Abdollahpour S, Khadivzadeh T | J Matern Fetal Neonatal Med
Aim: To improve the quality of care by health providers through what they need to know about coronavirus during pregnancy and childbirth.
6/4/20
Smith V, Deo D, Warty R, et al. | PLoS One
Aim: To systematically evaluate the literature and report the maternal and neonatal outcomes associated with COVID-19.
6/4/20
Santos VS, Gurgel RQ, Cuevas LE, et al. | J Pediatr Gastroenterol Nutr
Aim: To investigate differences in viral shedding in respiratory and fecal samples from children with COVID-19.
6/4/20
Zhang JJY, Lee KS, Ang LW, et al. | Clin Infect Dis
Aim: To review the evidence on predictors of severe disease and the efficacy of different treatments for COVID-19.
6/4/20
 | Health Technology, Wales
Aim: To review the evidence on the safety of personal protective equipment gowns for health and social care workers.
6/4/20
Mitchell S, Maynard V, Lyons V et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the role and response of primary care and community nursing services in the delivery of palliative care in epidemics and pandemics.
6/3/20
Yang M, Shang Y, Tian Z, et al. | Integr Med Res
Aim: To review the study characteristics of registered clinical trials on COVID-19 and provide guidance for future trials to avoid duplicated effort.
6/3/20
Nacif LS, Zanini LY, Waisberg DR, et al. | Clinics (Sao Paulo)
Aim: To collate available data on COVID-19 infection in solid organ transplantation (SOT) patients.
6/3/20
 | INESSS Quebec
6/3/20
Vestrheim DF, Iversen BG, Flottorp S, et al. | Norwegian Institute of Public Health
Aim: To review the evidence on the use of facemasks by asymptomatic personnel in long-term care facilities for primary prevention of COVID-19 infection.
6/3/20
Iannone P, Castellini G, Coclite D, et al. | PLoS One
Aim: To assess the efficacy of N95 respirators versus surgical masks for the prevention of respiratory tract infections transmission among HCWs.
UPDATED
6/2/20
Raymond M, Ching-A-Sue G, Van Hecke O | Oxford COVID-19 Evidence Service
Aim: To review the evidence on mast cell stabilizers, leukotriene antagonists, and antihistimines in COVID-19.
UPDATED
6/2/20
Boyd J, Davis A | Alberta Health Services
Aim: To review the various models, scenarios and thresholds that have been used internationally from past pandemics.
6/2/20
Liu M, Gao Y, Zhang Y, et al. | J Infect
Aim: To review the evidence on the assocation between severe or death COVID-19 and autoimmune disease.
6/1/20
Bolton L, Mills C, Wallace S, et al. | Int J Lang Commun Disord
Aim: To review the evidence underpinning the current healthcare policies in relation to AGPs, dysphagia assessment, and risk of transmission of and infection with COVID?19 in response to urgent clinical information needs.
6/1/20
Sanna G, Serrau G, Bassareo PP, et al. | Eur J Pediatr
Aim: To summarize all COVID-19 cases with a cardiac involvement published in paediatric age and explain the underlying mechanisms responsible for COVID-19-related myocardial damage.
6/1/20
Wang Y, Fang R, Zhang H, et al. | Dermatol Ther
Aim: To reveal the contribution of dermatologists in COVID-19 research.
6/1/20
Liu M, Gao Y, Shi S, et al  | J Infect
Aim: To quantitatively assess whether drinking is associated with the severity of COVID-19.
6/1/20
Chu DK, Akl EA, Duda S, et al. | Lancet
Aim: To investigate the effects of physical distance, face masks, and eye protection on virus transmission in health-care and non-health-care (eg, community) settings.
UPDATED
5/31/20
Lansbury L, Lim WS, Baskaran V, et al. | J Infect
Aim: To evaluate the burden of co-infections in patients with COVID-19.
UPDATED
5/29/20
Qu W, Wang Z, Hare JM, et al. | Stem Cells Transl Med
Aim: To review the available literature on safety, efficacy, and cytokine responses to MSC therapies in patients with ARDS.
5/29/20
Li X, Guan B, Su T, et al. | Heart
Aim: To assess the impact of underlying cardiovascular comorbidities and acute cardiac injury on in-hospital mortality risk.
5/29/20
 | INESSS Quebec
5/29/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how affected jurisdictions handled previously positive COVID-19 cases in the context of re-exposure/re-infection.
5/29/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on what serological tests are available and their sensitivities and specificities.
5/28/20
Hartmann-Boyce J, et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the risk and management of people of asthma during the COVID-19 pandemic.
5/28/20
Sutherland AE, Stickland J, Wee B | BMJ Support Palliat Care
Aim: To identify the highest currently available level of evidence to inform this major change in clinical practice.
5/28/20
Williams S, Walsh C | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the standards and practices that non-medical first responders should use in all activities with potential for exposure to high risk populations.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on risk stratification approaches to identify risk level in diabetes patients and clinical pathways to support diabetes management and service delivery.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk of domestic and family violence during the COVID-19 pandemic.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on fibrinolysis versus primary percutaneous coronary intervention in the treatment of ST-Elevation Myocardial Infarction (STEMI).
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence and guidelines on the use of PPE in COVID-19.
5/28/20
Sathian B, Asim M, Mekkodathil A, et al. | J Advances Intern Med
Aim: To conduct a systematic review of the literature on the impact of COVID-19 on community health.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the available guidelines on inpatient management of COVID-19.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on safe practice of intubation in the emergency department during the COVID-19 pandemic.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on large vessel occlusion stroke in patients with COVID-19.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk of newborn babies developing COVID-19.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on how the increasing use of NIPPV to manage suspected or confirmed COVID-19 patients led to any additional guidance regarding the physical requirements and engineering services.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on preservingc onsumer and patient partnership approaches during COVID-19.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the guidance for the provision of pulmonary rehabilitation for people recovering from COVID-19.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on supporting health systems to reduce adverse impacts on people with a lived experience of mental health issues during the COVID-19 pandemic.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the rehabilitation needs of post-acute COVID-19 patients and the appropriate timing of rehabilitation interventions.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of renal replacement therapies in intensive care units for patients with COVID-19?
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of santising and covering large medical equipment for COVID-19.
5/28/20
Dagens A, Sigfrid L, Cai E, et al. | BMJ
Aim: To appraise the availability, quality, and inclusivity of clinical guidelines produced in the early stage of the coronavirus disease 2019 (covid-19) pandemic.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on spirometry and whether it's an aerosol generating procedure, and the risk this procedure carries during the COVID-19 pandemic.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the available guidelines on temporary shared accomodations, particularly for people experiencing homelessness.
UPDATED
5/28/20
Checcucci E, Piramide F, Pecoraro A, et al. | Panminerva Med
Aim: To summarize the preliminary experiences and ongoing clinical trials of the major candidates and challenges of the vaccine strategies in humans.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effectiveness of mass thermal imaging in identifying people with COVID-19.
UPDATED
5/28/20
Zhen J, Chan C, Schoonees A, et al. | South African Med J
Aim: To assess the abilities of different interventions to decrease the incidence of droplet-based infections among people using public ground transport.
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on which tools are validated to diagnose respiratory illness via telehealth.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the proportion of COVID-19 cases in intensive care units that require ventilation.
UPDATED
5/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effective use of telemedicine or virtual care in different clinical areas.
5/27/20
Duran P, Berman S, Niermeyer S, et al. | Rev Panam Salud Publica
Aim: To describe perinatal and neonatal outcomes in newborns exposed to SARS-CoV-2.
5/27/20
Bergeron-Longpre M, Bertrand-Deschenes A | Center for Research in Public Health
Aim: To review the evidence on the impact of the pandemic on people and workers bereaved or confronted with death.
5/27/20
Moletta L, Peirobon ES, Capovilla G, et al. | Int J Surg
Aim: To review the available recommendations published by general Surgery Societies and Health Institutions and evaluate the underlying Literature.
5/27/20
Jain V, Yuan JM  | Int J Public Health
Aim: To identify specific symptoms and comorbidities predicting severe COVID-19 and intensive care unit (ICU) admission.
UPDATED
5/27/20
Albahri AS, Hamid RA, Alwan JK, et al. | J Med Syst
Aim: To obtain an overview of this critical virus, address the limitations of utilising data mining and ML algorithms, and provide the health sector with the benefits of this technique. 
5/27/20
Durand-Moreau Q, Adisesh A, et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the transmission of SARS-CoV-2 in meat and poultry facilities.
5/26/20
Hartmann-Boyce J, Lindson N | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the role of nicotine in COVID-19.
5/25/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the assessment and management of suspected or confirmed COVID-19 patients presenting to the Emergency Department (ED).
5/25/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the guidance to support health systems response to COVID-19 and associated risks for people experiencing homelessness.
5/25/20
Ahmed H, Patel K, Greenwood D, et al. | J Rehabil Med
Aim: To determine long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus infections after hospitalization or intensive care unit admission.
5/25/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on using wastewater surveillance to monitor the COVID-19 pandemic in the community.
5/23/20
Youssef M, Hussein M, Attia AS, et al. | J Med Virol
Aim: To find the association between liver injuries and the severity of COVID?19 disease.
5/22/20
Tian W, Jiang W, Yao J, et al. | J Med Virol
Aim: To evaluate the risk factors associated with mortality in COVID?19.
5/22/20
Kania-Richmond A, Sharpe H | Alberta Health Services
Aim: To review the evidence on the risk of transmission of COVID-19 via singing for aysmptomatic/presymptomatic and symptomatic people with COVID-19.
5/22/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on stigmatization related to COVID-19 in Canada.
5/22/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on the impact of the COVID-19 pandemic on Indigenous communitites in Canada.
5/21/20
Ludvigsson JF | Acta Paediatr
Aim: To review the evidence on the role of children in the transmission of SARS-CoV-2.
5/21/20
Mackey S, Warren C, Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the approaches being taken to migitate the risks associated with reopening schools.
5/20/20
Salem JB | Center for Research in Public Health
Aim: To review the evidence on the expression of the angiotensin 2 converting enzyme (ACE2) in children and adults.
5/20/20
Aiello F, Afflitto GG, Mancino R, et al. | Eye
Aim: To review the evidence on the presence of SARS-CoV-2 in cornea, conjunctiva, lacrimal sac, and tears in patients with COVID-19.
5/20/20
 | Sante Publique France
5/20/20
Park M | Vancouver Coastal Health
Aim: To review the evidence on re-opening child-related facilities and gatherings.
5/20/20
Hojaij FC, Chinelatto LA, Book GHP, et al. | Clinics
Aim: To analyze different perspectives concerning the COVID-19 pandemic, aiming to provide recommendations that could guide surgeons and entities toward screening, elective and emergency surgeries, decision making, and operating room management. 
5/19/20
Kasraeian M, Zare M, Vafaei H, et al. | J Matern Fetal Neonatal Med
Aim: To review the evidence on pregnancy outcome and neonates regarding COVID-19 pneumonia.
5/19/20
Juan J, Gil MM, Rong Z, et al. | Ultrasound Obstet Gynecol
Aim: To evaluate the effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes by performing a systematic review of available published literature on pregnancies affected by COVID-19.
5/19/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the risk and management of people with immunosuppression and COVID-19.
UPDATED
5/19/20
Tarassenko L, Greenhalgh T | Oxford COVID-19 Evidence Service
Aim: Can we use smartphones to measure oxygen saturation?
5/19/20
Kania-Richmond A, Koning C, Manhas KP | Alberta Health Services
Aim: To review the evidence on the rehabilitation needs of COVID-19 patients in ICU and in-patient hospital settings.
5/19/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence or published standards on telehealth implementation during the COVID-19 pandemic.
UPDATED
5/18/20
Gupta S, Parker J, Smits S, et al. | Colorectal Dis
Aim: To establish the incidence and timing of positive faecal samples for SARS-CoV-2 in patients with COVID-19.
5/18/20
Farsalinos K, Barbouni A, Niaura R | Intern Emerg Med
Aim: To systematically examine the prevalence of current smoking among hospitalized patients with COVID-19 in China, considering the high-population smoking prevalence in China (26.6%).
5/18/20
Yuen KF, Wang X, Ma F et al. | Int J Environ Res Public Health
Aim: To review, identify, and synthesise the causes of panic buying.
5/15/20
Montalvan V, Lee J, Bueso T, et al. | Clin Neurol Neurosurg
Aim: To review the neurological aspects of SARS-cov2 and other coronavirus, including transmission pathways, mechanisms of invasion into the nervous system, and mechanisms of neurological disease.
5/15/20
Lindquist I, Mackey K, Edwards S | VA Evidence Synthesis Program
Aim: To provide author feedback and critical appraisal in a similar manner as would be provided by editorial staff of a journal.
VA ESP
5/15/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on how physical distancing impacts mental health.
5/15/20
 | National Collaborating Centre for Methods and Tools
Aim: To review the evidence on indirect transmission in community settings.
5/14/20
Chauhan RP, Gordon ML | Pathogens
Aim: To summarize the original research articles and case reports of all the four types of influenza viruses reported in swine populations worldwide.
5/14/20
Yaacoub S, Schunemann H, Khabasa J, et al. | BMJ Global Health
Aim: To systematically review the literature to scope and assess the effects of specific strategies for the management of the bodies.
UPDATED
WHO COLLABORATIVE
5/14/20
Yang Z, Liu Y | Am J Perinatol
Aim: To summarize currently available evidence on vertical transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
5/13/20
 | ECRI
Aim: To examine the accuracy of external infrared temperature screening devices for identifying infected people.
5/13/20
da Silveira Fleck A, Ouedraogo DJ | Center for Research in Public Health
Aim: To review the evidence on the effects of automated calls or live call to assess the mental and physical health needs of elderly and/or vulnerable populations.
5/13/20
Mackey S, Warren C, Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the resumption of health care services in community or acute care.
5/13/20
 | ECRI
Aim: To review the evidence on the safety of extending the use of N95 respirator masks.
5/12/20
Yang Z, Wang M, Zhu Z, et al. | J Matern Fetal Neonatal Med
Aim: To summarize currently available evidence on maternal, fetal, and neonatal outcomes of pregnant women infected with Coronavirus Disease 2019 (COVID-19).
5/12/20
Tamara A, Tahapary DL | Diabetes Metab Syndr
Aim: To study the impact of obesity to the prognosis and disease severity of COVID-19.
5/12/20
Alqahtani JS, Oyelade T, Aldhahir AM, et al. | PLoS ONE
Aim: To summarize the evidence on the potential severity and mortality risks caused by COVID-19 in patients with COPD.
5/12/20
Ahmad E, Davies MJ, Khunti K | Oxford COVID-19 Evidence Service
Aim: To review the evidence on screening for and managing diabetic retinopathy during the COVID-19 pandemic.
5/12/20
Mehta MS, Mytton OT, Mullins EWS, et al. | Clin Infect Dis
Aim: To summarise current understanding of the epidemiology and transmission dynamics of this coronavirus in children, in order to inform decisions regarding clinical and public health measures for children in the UK.
5/12/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of baricitinib as a potential treatment for patients with COVID-19.
5/12/20
Abdelrahman T, Ansell J, Brown C, et al. | BJS Open
Aim: To identify contemporary evidence relating to OR practice in the context of COVID?19.
5/12/20
Li JW, Han TW, Woodward M, et al. | Prog Cardiovasc Dis
Aim: To summarize available data on severity differences in acute cardiac injury and acute cardiac injury with mortality during the COVID-19 outbreak.
5/11/20
Williams S, Walsh C, Bornstein S, et al. | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the significance of asymptomatic/pre-symptomatic transmission of COVID-19.
5/11/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of antimalarials, particularly chloroquine or hydroxychloroquine, to treat patients with COVID-19.
5/11/20
Bobrovitz N, Lee J, Mahtani KR | Oxford COVID-19 Evidence Service
Aim: To identify a priority list of evidence-based medications for use in the community or emergency department that could prevent emergency hospital admissions among non-COVID patients.  
5/11/20
Modayil M, Cook C, Cook L, et al. | Alberta Health Services
Aim: To review the evidence on the impact of virtual visits compared with or in addition to in-person visits on process outcomes, patient and provider satisfaction, quality of care, and access to provider.
5/11/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of protease inhibitors for treating COVID-19.
5/10/20
Neubeck L, Hansen T, Jaarsma T | Eur J Cardiovasc Nurs
Aim: To bring together the evidence for remote healthcare during a quarantine situation period to support people living with cardiovascular disease during COVID-19 isolation.
5/10/20
Parohan M, Yaghoubi S, Seraj A | Effects of temperature and humidity on the spread of COVID-19: A systematic review
Aim: To summarize available findings on the association between liver injury and severity of COVID-19 infection.
5/8/20
Juvet LK, Lauvrak V | Norwegian Institute of Public Health
Aim: To investigate if there are studies supporting the use of salivary samples for detection of SARS-CoV-2, and if there are studies that can be used to calculate the diagnostic accuracy of salivary testing compared to nasopharyngeal or oropharyngeal swab samples.
5/8/20
McQuillan R, Dozier M, Nundy R, et al. | UNCOVER
Aim: To review the evidence on the outdoor transmission of SARS-CoV-2 under the following different approaches: epidemiological, microbiological, mechanistic, and environmental.
5/7/20
Lloyd-Williams M, Mogan C, Karen SR, et al. | Oxford COVID-19 Evidence Service
Aim: To establish the evidence for which non-technology based activities that can be delivered at home by family carers, are effective in maintaining cognitive function in people with dementia who are socially isolating during COVID-19
5/7/20
Park M | Vancouver Coastal Health
5/7/20
Allsop M, Ziegler L, Fu Y, et al. | Oxford COVID-19 Evidence Service
Aim: To evaluate the evidence for oxygen as a treatment option to alleviate the symptoms of breathlessness for patients dying with COVID-19 and to identify potential harms.
5/7/20
Brurberg KG | Norwegian Institute of Public Health
Aim: To review the evidence on the transmission of SARS-CoV-2 via contact or droplets.
5/6/20
LeBlanc A | medRxiv
UPDATED
5/6/20
da Silveira Fleck A, Ouedraogo DJ | Center for Research in Public Health
Aim: To review the evidence on the effectiveness of disinfection methods for disposable filtering face pieces of type N95.
5/6/20
Chen J | Alberta Health Services
Aim: To review the evidence on the use of antibacterial therapy upon admission for patients with respiratory symptoms who have suspected or confirmed COVID-19.
5/6/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of interleukin-6 (IL-6) inhibitors, particularly tocilizumab, to manage symptoms of patients with COVID-19.
5/6/20
Tong JY, Wong A, Zhu D, et al. | Otolaryngol Head Neck Surg
Aim: To determine the pooled global prevalence of olfactory and gustatory dysfunction in patients with the 2019 novel coronavirus (COVID-19).
5/6/20
Theodoratou E, Dozier M, Li X, et al. | UNCOVER
Aim: To review the evidence on COVID-19 transmission routes among infected children and adolescents.
5/5/20
Biro S | KFL&A Public Health
Aim: To review the evidence on the factors, considerations, and criteria that should be in place to limit infection risk while lifting restrictions at a regional level in Canada.
5/5/20
Razaq A, Harrison D, Karunanithi S, et al. | Oxford COVID-19 Evidence Service
Aim: To evaluate the evidence on plausible associations between ethnicity and COVID-19 incidence and adverse health outcomes in the general population and people working in health and social care.
5/5/20
Balla M, Merugu GP, Patel M, et al. | J Clin Med Res
Aim: To provide a comprehensive clinical summary of all the available data from high-quality research articles relevant to the epidemiology, demographics, trends in hospitalization and outcomes, clinical signs and symptoms, diagnostic methods and treatment methods of COVID-19, thus increasing awareness in health care providers. 
5/5/20
Biro S | KFL&A Public Health
5/5/20
 | Health Information and Quality Authority, Ireland
Aim: To identify a wide range of diagnostic tests for detecting and confirming COVID-19 cases.
5/5/20
 | Sante Publique France
5/4/20
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the transmission of COVID-19 in outdoor settings.
5/4/20
Juvet LK, Laake I, Vestrheim DF | Norwegian Institute of Public Health
Aim: To review the literature on the case fatality rate and infection fatality rate for serious cases of COVID-19.
5/4/20
Flodgren GM | Norwegian Institute of Public Health
Aim: To review the evidence on immunity to COVID-19 after infection by SARS-CoV-2.
5/4/20
Tarassenko LJ, McManus R, Greenhalgh T | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the accuracy of the Lifelight app to measure blood pressure.
5/4/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of remdesivir as a potential treatment for patients with COVID-19.
5/4/20
Mackey S, Warren C | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the role of children in the transmission of COVID-19.
5/2/20
Rawson TM, Moore L, Zhu N, et al. | Clin Infect Dis
Aim: To explore and describe the current literature surrounding bacterial/fungal co-infection in patients with coronavirus infection.
5/1/20
 | INESSS, Quebec
Aim: To evaluate the safety and efficacy of cholorquine and hydroxychloroquine in COVID-19.
5/1/20
Li Y, Nair H, Kulkarni D, et al. | UNCOVER
Aim: To review the evidence on how population-level non-pharmaceutical interventions to reduce the transmission of COVID-19 is related to the reproduction number R.
5/1/20
Williams S, Walsh C, Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on the liklihood of reinfection and the significance of sustained viral detection after incubation period is complete.
5/1/20
Lee J, van Hecke O, Roberts N | Oxford COVID-19 Evidence Service
Aim: To review the clinical evidence that vitamin D has a role in preventing or treating COVID-19.
4/30/20
Shiozawa P, Uchida RR | Braz J Psychiatry
Aim: To review the evidence on emergency psychological crisis intervention during the COVID-19 outbreak.
4/30/20
Hartmann-Boyce J, Lindson N | Oxford COVID-19 Evidence Service
4/30/20
Brurberg KG | Norwegian Institute of Public Health
Aim: To review the evidence on the role of children in the transmission of SARS-CoV-2.
4/29/20
Janssens GO, Mandeville HC, Timmermann B, et al. | Radiother Oncol
Aim: To derive evidence-based recommendations for the optimal utilisation of resources during unexpected shortage of radiotherapy capacity.
4/29/20
 | INESSS, Quebec
Aim: To identify alternative drugs to propofol currently used in the constitution of marketing authorization kits while taking into account current and anticipated stock-outs of alternative drugs.
4/29/20
Hoang U, Jones NR | Oxford COVID-19 Evidence Service
Aim: To determine if there is an association between ambient air pollution and severity of COVID-19 infection. 
4/29/20
Checkley S, Rogers L, Caffrey N, et al. | Alberta Health Services
Aim: To review the evidence that centralized voluntary isolation/quarantine centers (CVICs) reduce transmission and spread.
4/29/20
Asadi L | Alberta Health Services
Aim: To explore evidence based strategies beyond home self-isolation and use of centralized voluntary isolation centers (eg: wearing masks within the home; additional cleaning; testing, other) that have been used to successfully control focal COVID-19 outbreaks in other settings.
4/29/20
Boyd J | Alberta Health Services
Aim: To review the evidence on whether there are populations of asymptomatic individuals (e.g., population sampling; congregate living including LTC, vulnerable populations; patients being hospitalized, those associated with outbreaks, HCWs) that should be considered priority for screening for COVID 19 infection (with RTPCR), with the goal of surveillance and preventing spread within these populations.
4/29/20
McQuillan R, Dozier M, Theodoratou E, et al. | UNCOVER
Aim: To review the evidence on differences in COVID-19 incidence and outcomes based on ethnic variation.
4/28/20
Park M | Vancouver Coastal Health
Aim: To review the evidence on lockdown de-escalation measures in response to COVID-19.
4/28/20
 | ECRI
Aim: To review evidence and guidelines on interventions to supplement standard weaning practices to reduce ventilator time and avoid repeat intubation in patients with COVID-19.
4/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the guidance on the management of acute behavioural disturbance during COVID-19.
4/28/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of favipiravir for treating COVID-19.
4/28/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of nonsteroidal anti-inflammatory drugs (NSAIDs), particularly ibuprofen, to manage symptoms of COVID-19.
4/28/20
Gbinigie K, Frie K | Oxford COVID-19 Evidence Service
Aim: To evaluate the evidence for the safety and effectiveness of using macrolides to treat COVID-19.
4/27/20
 | ECRI
Aim: To examine the effectiveness of triage systems for identifying disease severity and mortality risk to inform decisions on scarce resource allocation during pandemics.
4/27/20
Minotti C, Tirelli F, Barbieri E, et al. | J Infect
Aim: To systematically review the current knowledge on SARS-CoV-2 cases in children and adults with immunosuppression, to evaluate outcomes in this special population.
4/27/20
Kernohan A, Boath A, Calderon M, et al. | Oxford COVID-19 Evidence Service
Aim: To identify relevant studies to inform evidence-based patient management and care pathway development.
4/27/20
Ali H, Daoud A, Mohamed MM, et al. | Ren Fail
Aim: To explore the survival outcome of COVID-19 subjects who developed severe AKI, the latter defined as subjects who require acute renal replacement therapy (RRT) or meet the Kidney Disease Improving Global Outcome (KDIGO) definition of AKI stage III.
4/27/20
Wilson, MG, Waddell K, Gauvin FP, et al. | McMaster Health Forum
Aim: To identify evidence on international and Canadian experiences with asymptomatic screening to identify COVID-19 cases and to prevent transmission.
4/26/20
Williams S, Walsh C, Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on cohorting of residents in long-term care facilities who test positive for COVID-19.
4/25/20
Chauhan R, Dessie ZG, Noreddin A, et al. | Pathogens
Aim: To highlight the available information about viral diseases, including zoonotic and vector-borne diseases, reported in Africa to better understand the trend of emerging and re-emerging virus diseases within the African continent.
4/24/20
Couper K, Taylor-Phillips S, Grove A, et al. | Resuscitation
Aim: To identify the potential risk of transmission associated with key interventions (chest compressions, defibrillation, cardiopulmonary resuscitation) to inform international treatment recommendations.
4/24/20
 | INESSS, Quebec
Aim: To examine the evidence on COVID-19 in pediatric clinical care.
4/24/20
Soliman R, Brassey J, Pluddemann A, et al. | Oxford COVID-19 Evidence Service
Aim: To evaluate the current evidence about the protective effects of BCG vaccine against acute respiratory infections and COVID-19.
4/24/20
Brett K, Walter M | CADTH
Aim: To examine the evidence regarding the clinical effectiveness of plastic or reusable aerochambers in multi-dose inhalers for patients requiring medication administration, as well as any evidence-based guidelines on the topic.
4/24/20
Kumar D, Severn M | CADTH
Aim: To identify available evidence on the clinical effectiveness of portable or temporary negative pressure rooms and related evidence-based guidelines for the management of people with active tuberculosis.
4/23/20
Castagnoli R, Votto M, Licari A, et al. | JAMA Pediatr
Aim: To evaluate currently reported pediatric cases of SARS-CoV-2 infection.
4/22/20
Erdmann R, Kania-Richmond A | Alberta Health Services
Aim: To review the evidence on whether patients who are on prescribed NSAIDS as chronic therapy should stop taking these drugs if they develop COVID-19.
4/22/20
Chastenay M | INESSS, Quebec
Aim: To review the evidence on social and mental health services to promote a return to normal life during the recovery phase of a pandemic or similar crisis.
4/22/20
Kalin A, Waqar S, Ghouri N, et al. | Oxford COVID-19 Evidence Service
Aim: To provide guidance to clinicians looking after patients with symptoms of COVID-19 who are thinking about fasting in Ramadan.
4/22/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on community or home-based non-invasive ventilation (NIV) and inspiratory muscle training (IMT) for people with spinal cord injuries during COVID-19.
4/22/20
Hu Y, Sun J, Dai Z, et al. | J Clin Virol
Aim: To evaluate the risk factors of COVID-19. 
4/22/20
Jelinski S, Mackay E | Alberta Health Services
Aim: To review the evidence on patient demographic or clinical factors that are associated with positive COVID-19 test results.
4/22/20
Clement F  | University of Calgary
Aim: To review the clinical evidence for the risk of transmission of acute respiratory infections to health care workers caring for patients undergoing aerosol-generating medical procedures.
4/22/20
Stravropoulou C, Palmer VJ, Burls A, et al. | Oxford COVID-19 Evidence Service
Aim: To examine the evidence on the conditions that most often lead to potentially preventable unplanned hospital admissions that are manageable in primary care.
4/22/20
Urwin SG, Kandola G, Graziado S | Oxford COVID-19 Evidence Service
Aim: To provide a quick reference summary of prognostic clinical risk prediction scores that are currently available in an accessible format and methodologically suitable for use in the community following a potential infection with the SARS-CoV-2 virus causing COVID-19, or people with suspected or confirmed COVID-19.
4/22/20
Sharpe H, McLane P | Alberta Health Services
Aim: To review the evidence on criteria or simple tools that can be used to determine which patients with suspected/confirmed COVID-19 are stable and appropriate for safe discharge from hospital or an alternate care centre.
4/22/20
Carver C, Guyan M, Pierre M | UNCOVER
Aim: To review the evidence on which high proximity activites in the UK would benefit from mask wearing to reduce the transmission of COVID-19.
4/21/20
Strict A, Hartmann K, Armann J, et al. | Übersichten
Aim: To summarize the current scientific evidence on the clinical course of COVID-19 in hospitalized children.
4/21/20
Chang T, Wu J, Chang L | J Formos Med Assoc
Aim: To collect current evidence about COVID-19 in children.
4/21/20
 | INESSS, Quebec
Aim: To examine the evidence on COVID-19 and breastfeeding.
4/21/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on preoperative testing of COVID-19 for patients undergoing surgery.
UPDATED
4/21/20
Greenhalgh T, Javid B, Knight M, et al. | Oxford COVID-19 Evidence Service
Aim: To review the evidence on tests to confirm or exclude exertional desaturation.
4/20/20
Jones N, Carver C | Oxford COVID-19 Evidence Service
Aim: Does current evidence support social distancing of asymptomatic healthcare workers from other household members or other interventions specific to healthcare workers to reduce the risk of transmitting COVID-19?
4/20/20
 | ECRI
Aim: To review the evidence on the general public’s use of these face coverings for reducing the transmission risk of viral respiratory infection.
4/20/20
Roncon L, Zuin M, Rigatelli G, et al. | J Clin Virol
Aim: To assess the risk of ICU admission and morality risk in diabetic COVID-19 patients.
4/20/20
 | Health Technology Wales
Aim: To review the evidence on the effectiveness of virus and antibody tests to inform COVID-19 diagnosis.
4/20/20
Greenhalgh T, Treadwell J, Burrow R, et al. | Oxford COVID-19 Evidence Service
Aim: In people in the community with suspected or confirmed COVID-19, are there demographic features, other conditions, symptoms, or signs that are prognostic factors for 30-day all-cause mortality, ventilation, or ICU care?
4/20/20
Waddell K, Gauvin FP, Wilson MG, et al. | McMaster Health Forum
Aim: To identify evidence on the spread and management of COVID-19 in non-health workplaces, including workplaces where light-touch services are offered such as government administration offices (e.g., Service Canada or Service Ontario) and social services (e.g., group homes for high-needs individuals).
4/20/20
Theodoratou E, Dozier M, Guyan M, et al. | UNCOVER
Aim: To review the evidence on the efficacy of face masks in preventing respiratory transmission in the community.
4/20/20
Cunningham C, Cook C | Alberta Health Services
Aim: To review the evidence on predictive tools or tests that can assist in deciding who is at risk of clinical deterioration and should be assessed in the emergency department.
4/19/20
McQuillan R, Narain A, Dozier M | UNCOVER
Aim: To review the evidence on the efficacy of homemade facemaks at reducing transmission of COVID-19 in community settings.
4/19/20
Santoso A, Pranata R, Wibowo A, et al. | Am J Emerg Med
Aim: To explore the association between cardiac injury and mortality, the need for intensive care unit (ICU) care, acute respiratory distress syndrome (ARDS), and severe coronavirus disease 2019 (COVID-19) in patients with COVID-19 pneumonia
4/19/20
 | UNCOVER
Aim: To review the evidence on the effect of face masks in the general population in reducing the spread of infection.
4/18/20
Della Gatta A, Rizzo R, Pilu G, et al. | Am J Obstet Gynecol
Aim: To conduct a systematic review of the clinical outcomes reported for pregnant patients with coronavirus disease 2019.
UPDATED
4/18/20
Gatta D, Nunzia A, Rizzo R, et al. | Am J Obstet Gynecol
Aim: To conduct a systematic review of the outcomes reported for pregnant patients with COVID 19. 
4/17/20
Romney D, Fox H, Carlson S, et al. | Disaster Med Public Health Prep
Aim: To locate and analyze U.S. State Crisis Standards of Care (CSC) documents to determine their prevalence and quality.
4/17/20
Song Y, Ren F, Sun D, et al. | Int J Environ Res Public Health
Aim: To summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults.
4/17/20
 | National Collaborating Centre for Environmental Health
Aim: To review the evidence on precautions needed to mitigate community spread of SARS-CoV-2 in outdoor environment
4/17/20
 | INESSS, Quebec
Aim: To evaluate the efficacy of remdesivir in post-exposure prophylaxis of SARS-Cov2 infection.
4/17/20
Brurberg KG, Fretheim A | Norwegian Institute of Public Health
Aim: To review the evidence on the association between age, comorbidity, and disease severity in patients with COVID-19.
4/17/20
Huang I, Lim MA, Pranata R | Diabetes Metab Syndr
Aim: To investigate the association between DM and poor outcome in patients with COVID-19 pneumonia.
4/17/20
Dulong C, Frey N, Walter M | CADTH
Aim: To summarize studies on the clinical effectiveness of using pre-dental treatment mouth rinses for patients with suspected SARS or COVID-19 in order to prevent virus transmission from patients to oral health care providers.
4/17/20
 | Singapore Ministry of Health
Aim: To review the evidence on the use of convalescent plasma in patients with COVID-19.
4/16/20
 | INESSS, Quebec
Aim: To evaluate the safety and efficacy of using biotherapies directed againts IL-6 or its receptor in COVID-19.
4/16/20
 | INESSS, Quebec
Aim: To review the evidence on palliative care and drug shortages during the COVID-19 pandemic.
4/16/20
 | INESSS, Quebec
Aim: To review the evidence on alternative drugs for sedation during the COVID-19 pandemic.
4/16/20
McCall MC, Heneghan C, Nunan D | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the effectiveness of physical exercise in preventing or treating acute respiratory infection.
4/16/20
Hastings S, et al. | Alberta Health Services
Aim: To explore the evidence for and risks of using hydroxychloroquine (HQ) as a treatment and prophylaxis for SARS-CoV-2.
4/16/20
Pujadas-Botey A | Alberta Health Services
Aim: To review the evidence on strategies for assessing patients who were infected with COVID-19 for suitability for starting or resuming cancer treatment.
4/16/20
Kostaras X | Alberta Health Services
4/16/20
Coles B, Burton C, Khunti K, et al. | Oxford COVID-19 Evidence Service
Aim: What is the efficacy of aprons compared to gowns in primary care settings?
4/16/20
Coles B, Burton C, Khunti K, et al.  | Oxford COVID-19 Evidence Service
Aim: To review the efficacy of protective gowns versus aprons in primary care settings.
4/15/20
Muhidin S, Moghadam ZB, Vizheh M | Arch Acad Emerg Med
Aim: To clarify the impact of novel coronavirus disease (COVID-19) on pregnant patients and maternal and neonatal outcomes.
4/15/20
Hastings S, et al. | Alberta Health Services
Aim: To explore how the testing characteristics for the Alberta Health Services lab-developed test for COVID-19 differ between samples collected from nasal, nasopharyngeal, and throat swabs.
4/15/20
MacPherson F | BC Ministry of Health
Aim: To identify which infection prevention and control interventions, programs, infrastructure are most effective at reducing health care associated infections in Long Term Care facilities.
4/15/20
 | INESSS, Quebec
Aim: To review the evidence on general considerations for cancer treatment in patients with COVID-19.
4/15/20
 | INESSS, Quebec
Aim: To review the evidence on single dose neoadjuvant radiotherapy for the treatment of breast cancer where the surgery cannot be performed within a reasonable time.
4/15/20
 | Ontario Health Quality
Aim: To examine the recommendations and literature on the extended use and layering of N95 respirators and use of expired personal protective equipment during the COVID-19 pandemic.
4/15/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the pyschological impact of COVID-19 on healthcare workers.
4/14/20
Zuin M, Rigatelli G, Zuliani G, et al. | J Infect
Aim: To evaluate the risk of death in COVID-19 infection patients with and without HT.
4/14/20
 | NICE
Aim: To assess the best available evidence to determine the risk of developing COVID-19 due to acute use of NSAIDs and if doing so can lead to increased risk of developing more severe symptoms of COVID-19.
4/14/20
Koshkouei M, Abel L, Pilbeam C | Oxford COVID-19 Evidence Service
Aim: To evaluate available measures to minimise the risk of infection spread among residents and staff within care home settings.
4/14/20
Ferner RE, Aronson JK | Oxford COVID-19 Evidence Service
Aim: To examine the protocols and preliminary trial reports of early clinical trials involving hyroxychloroquine.
4/14/20
Dorward J, Gbinigie K | Oxford COVID-19 Evidence Service
Aim: To review the evidence for the use of Lopinavir/ritonavir (LPVr) as a treatment for COVID-19.
4/14/20
Van Hecke O, Lee J | Oxford COVID-19 Evidence Service
Aim: To conduct a rapid review of NAC with specific emphasis on its potential for early administration in the community for patients at greater risk of severe COVID-19.
4/14/20
Wilson MG, Gauvin FP, Waddell K, et al. | McMaster Health Forum
Aim: To identify evidence on strategies for conserving, re-using, and repurposing different kinds of masks.
4/13/20
Hastings S, et al. | Alberta Health Services
Aim: To explore the evidence supporting the possibility of asymptomatic transmission of SARS-CoV-2.
4/13/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on emerging tools that are being used to support communication between patients and their loved ones during the COVID-19 pandemic.
4/13/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the triage tools that are available to guide decisions about admission to ICU during COVID-19.
4/12/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the use of dedicated hospitals and wards exclusively for the use of COVID-19 patients.
4/12/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the organization of palliative care services during COVID-19 (or previous pandemics).
4/11/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence about COVID-19 modes of transmission?
4/10/20
Jelinski S | Alberta Health Services
Aim: To review the evidence on risk prediction tools to guide admission disposition and management decisions for patients with COVID-19 who are admitted to the hospital.
4/10/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether continuous positive airway pressure (CPAP) and/or Bilevel Positive Airway Pressure (BiPAP) are aerosol generating, and to locate guidelines on the use of CPAP as a substitute for ventilators during the COVID-19 pandemic.
4/10/20
Sharpe H | Alberta Health Services
Aim: To review the evidence on clinical features that reliably indicate need for intubation or mechanical ventilation.
4/10/20
McLane P | Alberta Health Services
Aim: To review the evidence on admission or safe discharge of patients with suspected or confirmed COVID-19 from the emergency department
4/9/20
 | INESSS, Quebec
Aim: To evaluate the use of the lopinavir-ritonavir combination in post-exposure prophylaxis of SARS-Cov2 infection.
4/9/20
Chastenay M | INESSS, Quebec
Aim: To review the evidence on maintaining a community safety net for children and youth at risk of being abused during a pandemic.
4/9/20
Dulong C, MacDougall D | CADTH
Aim: To search for evidence-based guidelines related to the use of digital stethoscopes for pulmonary auscultation in patients with suspected or confirmed infectious disease.
4/9/20
Kumar D, Walter M, Frey N | CADTH
Aim: To review the available evidence on the lifespan of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on different materials, as well as its potential for transmission via these materials
4/8/20
Russel B, Moss C, George G, et al. | Ecancermedicalscience
Aim: To examine the effects of immuno-suppressive and stimulating drugs on host immunity against COVID-19.
4/8/20
Chastenay MH | INESSS, Quebec
Aim: To review the evidence on the effectiveness and feasibility of assessing autism spectrum disorder in children remotely in the context of the COVID-19 pandemic.
4/8/20
Hartmann-Boyce J, Morris E, Goyder C, et al. | Oxford COVID-19 Evidence Service
4/8/20
Heneghan C, Pluddemann A, Mahtani KR | Oxford COVID-19 Evidence Service
4/8/20
Hartmann-Boyce J, Morris E, Goyder C, et al. | Oxford COVID-19 Evidence Service
4/8/20
Greenhalgh T, Treadwell J, Burrow R, et al. | Oxford COVID-19 Evidence Service
Aim: To establish the state of knowledge, ignorance and uncertainty in relation to the use of NEWS2 in the context of COVID-19 in primary care.
4/8/20
Chastenay MH | INESSS, Quebec
Aim: To review the evidence on psychological distress and mental health in healthcare workers during the COVID-19 pandemic.
4/8/20
Hastings S | Alberta Health Services
Aim: To review the evidence on whether people with previous COVID-19 infection can become re-infected by the SARS-CoV-2 virus.
4/8/20
El-Jardali F, Fadlallah R, Daher N, et al. | Knowledge to Policy Center
Aim: To provide guidance for suppressing COVID-19 through community-centered care approach.
4/8/20
Rios P, Radhakrishnan A, Antony J, et al. | Oxford COVID-19 Evidence Service
Aim: To identify safe and effective medical countermeasures to address the current outbreak of a novel coronavirus (COVID-19).
4/8/20
Green K, Allen AJ, Suklan J | Oxford COVID-19 Evidence Service
Aim: To describe the approaches to clinical investigations following a negative RT-PCR results as described in guidelines from China, Italy, Spain, UK and US. 
4/7/20
 | Ontario Health Quality
Aim: To examine the recommendations and literature on cloth (fabric) masks during the COVID-19 pandemic.
4/7/20
Green K, Graziadio S, Turner P, et al. | Oxford COVID-19 Evidence Service
Aim: To summarize the characteristics of current molecular and antibody diagnostic tests available to support the diagnosis and management of patients with suspected COVID-19.
4/7/20
 | Ontario Health Quality
Aim: To examine the recommendations and literature on N95 equivalents from other countries during the COVID-19 pandemic.
4/7/20
 | Ontario Health Quality
Aim: To examine the guidelines and published literature on 3D printing of N95 respirators and face shields during the COVID-19 pandemic.
4/7/20
Khunti K | Oxford COVID-19 Evidence Service
4/6/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on whether cardiopulmonary resuscitation is aerosol generating.
4/6/20
Navarro P | Newfoundland and Laborador Centre for Applied Health Research
Aim: To review the evidence on effective interventions for homeless people during the COVID-19 pandemic.
4/6/20
 | INESSS, Quebec
Aim: To document the ethical guidelines for demonstrating treatment effectiveness by clinical research.
4/6/20
Heneghan C, Brassey J, Jefferson T | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the proportion of COVID-19 cases that are asymptomatic.
4/6/20
McCall MC, Nunan D, Heneghan C | Oxford COVID-19 Evidence Service
4/4/20
 | INESSS, Quebec
Aim: To review the evidence on the use of NSAIDS in pediatric patients with confirmed or suspected COVID-19.
4/4/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on appropriate PPE for healthcare workers providing routine intrapartum care during the COVID-19 outbreak and other respiratory pandemics.
4/3/20
 | Ontario Health Quality
Aim: To examine the guidelines and published literature on the use of PAPRs as an alternative to N95 respirators in a health care setting.
4/3/20
Berg C, Nokleby H | Norwegian Institute of Public Health
Aim: To review the evidence on electronic follow-up of children and youth in childcare institutions.
4/3/20
McLane P, Leal J | Alberta Health Services
Aim: To review the evidence on managing the clothing and personal items of healthcare workers across various health care settings to reduce the risk of self-contamination and to reduce the risk of transmitting the virus outside the hospital.
4/3/20
Sharpe H, Kania-Richmond A, Leal J | Alberta Health Services
Aim: To review the evidence on the risk of COVID-19 transmission associated with oxygen therapy.
4/3/20
Chastenay MH | INESSS, Quebec
Aim: To review the evidence on effective approaches with patients requiring psychiatric care and who have or are at risk of having COVID-19.
4/3/20
Khunti K, et al. | Oxford COVID-19 Evidence Service
4/2/20
Greenhalgh, T | Oxford COVID-19 Evidence Service
4/2/20
McQuillan R, Dozier M, Harpur A, et al. | UNCOVER
Aim: To review the evidence on the importance of outdoor transmission and of indoor transmission of COVID-19.
4/1/20
Brurberg KG, Fretheim A | Norwegian Institute of Public Health
Aim: To review the evidence on the risk of aerosol-related transmission of SARS-CoV-2.
4/1/20
 | INESSS, Quebec
Aim: To review the evidence on the use of nitrous oxide during childbirth in women with confirmed or suspected COVID-19.
4/1/20
 | Health Technology Wales
Aim: To review evidence on the Jafron device or other haemoperfusion adsorption cartridges for the treatment of cytokine storm, particularly in people with COVID-19.
4/1/20
 | Health Technology Wales
Aim: To review evidence that reported levels of residual hydrogen peroxide (HP) after use of HP vapour to decontaminate PPE, in particular respirators and isolation/surgical gowns.
4/1/20
 | Health Information and Quality Authority, Ireland
Aim: To review the evidence on the spread of COVID-19 by children.
4/1/20
Sharpe H | Alberta Health Services
Aim: To review the evidence on the recommendeduse of non-invasive ventilation in AHS acute care facilities during the COVID-19 pandemic.
4/1/20
Michelen M, Jones N, Stavropoulou C | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the symptoms and clinical features of mild and moderate cases of COVID-19.
4/1/20
Michelen M, Jones N, Stavropoulou C | Oxford COVID-19 Evidence Service
4/1/20
 | ECRI
Aim: To examine the safety and effectiveness of off-label use of these intermittent BiPAP and CPAP machines as temporary ventilator support for critically ill patients during ventilator shortages.
4/1/20
 | ECRI
Aim: To review the safety and efficacy of sharing a ventilator between multiple patients.
4/1/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on how seasonal changes could impact the COVID-19 pandemic.
3/31/20
Park M, Cook AR, Lim JT, et al. | J Clin Med
Aim: To summarize the available evidence on transmission dynamics, severity, susceptibility and control measures to inform policymakers and leaders in formulating management guidelines and to provide directions for future research
3/31/20
Chastenay M | INESSS, Quebec
Aim: To review the evidence on current intervention practices with children with ID, ASD, or PD internationally in the context of a pandemic.
3/31/20
Chastenay MH | INESSS, Quebec
Aim: To shed light on the identification of useful means or potential means to promote the maintenance of social interactions between caregivers and vulnerable people.
3/31/20
 | INESSS, Quebec
Aim: To evaluate the use of assive antibody therapy (convalescent plasma) for the treatment of COVID-19.
3/31/20
Chastenay MH | INESSS, Quebec
Aim: To document the harmful effects of the COVID-19 pandemic on the mental health of the population and the measures to put in place to counter these effects.
3/31/20
Chastenay MH | INESSS, Quebec
Aim: To review the evidence on the criteria and the precautions to be implemented in the case of a load shedding in a psychiatric environment in the context of the health emergency linked to COVID-19 and the alternative measures to be implemented if necessary.
3/31/20
Fadlallah R, Daher N, El-Jardali F | Knowledge to Policy Center
Aim: To promote and strengthen the role of local and international NGOs in the COVID-19 response.
3/30/20
Hafizi D, Walter M, MacDougall D | CADTH
Aim: To examine the clinical effectiveness of masks for clinicians and health care workers exposed to bioaerosols or infectious agents during ears, nose and throat (ENT) procedures.
3/30/20
Kalin, A  | Oxford COVID-19 Evidence Service
Aim: To review the evidence on oral long-term immunosuppression in patients with respiratory disease.
3/30/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the effects of the COVID-19 pandemic on healthcare workers in terms of infections.
3/29/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on existing models for redeploying staff during the COVID-19 pandemic.
3/28/20
Hartmann-Boyce J, Davies N, Frost R, et al.  | Oxford COVID-19 Evidence Service
Aim: To evaluate the evidence for interventions to maximise mobility in older people, and minimise deterioration in activity and frailty levels.
3/28/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence for the prone position in patients with COVID-19.
3/27/20
 | INESSS, Quebec
Aim: To review the safety and effiacy of abortion methods during the COVID-19 pandemic.
3/26/20
Carver C, Jones N | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the comparative accuracy of oropharyngeal and nasopharyngeal swabs to diagnose COVID-19.
3/26/20
Aronson JK | Oxford COVID-19 Evidence Service
3/26/20
Carver C, Jones N | Oxford COVID-19 Evidence Service
3/26/20
Heneghan C, Brassey J, Jefferson T | Oxford COVID-19 Evidence Service
3/25/20
Tierney s, Mahtani KR, Turk A | Oxford COVID-19 Evidence Service
Aim: To review the evidence on how social prescribing can be best implemented within the current COVID-19 pandemic.
3/25/20
Frie K, Gbinigie K | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the effectiveness of chloroquine and hydroxychloroquine in treating COVID-19.
3/25/20
 | INESSS, Quebec
Aim: To document the effect of colchicine on the inflammatory cascade accompanying certain severe forms of severe acute respiratory syndrome caused by coronaviruses.
3/25/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on the safety of laparoscopy during the COVID-19 pandemic.
3/25/20
Rios P, Radhakrishnan A, Thomas SM, et al. | Oxford COVID-19 Evidence Service
Aim: To identify evidence on infection protection and control measures for adults aged 60 years and older in long-term care settings from systematic reviews.
3/25/20
Mahtani KR, MacKenna B, Spencer E | Oxford COVID-19 Evidence Service
Aim: To review the evidence on prescribing longer repeat prescriptions for patients with long-term conditions during a pandemic.
3/25/20
Hartmann-Boyce J, Mahtani KR | Oxford COVID-19 Evidence Service
Aim: To review the evidence on management of LTCs during pandemics and national emergencies, to evaluate the indirect risks posed by these situations, and to summarise the strategies proposed to mitigate these risks.
3/24/20
Greenhalgh T, Chan XH, Khunti K, et al.  | Oxford COVID-19 Evidence Service
Aim: To review the evidence on respiratory protective measures e.g. use of face masks as PPE, to reduce droplet and airborne spread. 
3/23/20
Aronson JK, Ferner RE | Oxford COVID-19 Evidence Service
3/23/20
Greenhalgh T, Kotze K, Van Der Westhuizen H | Oxford COVID-19 Evidence Service
3/23/20
 | INESSS, Quebec
Aim: To evaluate the safety and efficacy of using Amantadine/Rimantadine in COVID-19 patients.
3/23/20
 | INESSS, Quebec
Aim: To evaluate the administration of an interferon as monotherapy for the treatment of patients with a confirmed or suspected diagnosis of COVID-19.
3/23/20
 | INESSS, Quebec
Aim: To evaluate the use of oseltamivir for the treatment of patients with a confirmed or suspected diagnosis of COVID-19.
3/23/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on drug therapies being used to combat COVID-19.
3/23/20
Brassey J, Heneghan C | Oxford COVID-19 Evidence Service
3/23/20
Hoang U | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the accuracy of wrist style BP cuffs.
3/23/20
Brurberg KG | Norwegian Institute of Public Health
Aim: To review the evidence on the risk of airborne transmission of SARS-CoV-2, MERS-CoV, and SARS-CoV.
3/23/20
O’Donovan J, Tanveer S, Jones N, et al. | Oxford COVID-19 Evidence Service
3/22/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the advice being provided by medical colleges regarding the COVID-19 pandemic.
3/22/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the advice being provided by international medical colleges regarding the COVID-19 pandemic.
3/22/20
 | Singapore Ministry of Health
Aim: To review the evidence on the effect of ACE inhibitors and angiotensin II receptor blockers on patients with COVID-19.
3/22/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the advice being provided by surgical specialities regarding COVID-19.
3/20/20
 | INESSS, Quebec
Aim: To review the evidence on the use of ACE inhibitors and ARBs in the context of the COVID-19 pandemic.
3/20/20
 | INESSS, Quebec
Aim: To review the evidence on the use of NSAIDS in patients with confirmed or suspected COVID-19.
3/20/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence and expert advice regarding the use of ECMO for COVID-19 patients.
3/20/20
Pluddemann A, Hobbs R, Mahtani KR, Heneghan C | Oxford COVID-19 Evidence Service
3/20/20
Ferner RE, Murray PI, Aronson JK | Oxford COVID-19 Evidence Service
3/20/20
 | NSW Health COVID-19 Critical Intelligence Unit
Aim: To review the evidence on telemedicine models or interventions associated with improved outcomes for people in the ICU.
3/20/20
Nunan D, Brassey J | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the effect of restricting and cancelling mass gatherings and sporting events on infectious diseases.
3/20/20
Mahtani KR, Heneghan C, Aronson JK | Oxford COVID-19 Evidence Service
3/18/20
Brassey J, Heneghn C | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the accuracy of strip-like forehead thermometers in detecting fevers.
3/18/20
Hartmann-Boyce J, Hobbs R | Oxford COVID-19 Evidence Service
Aim: To review the evidence on the relationship between the use of inhaled corticosteroids and COVID-19 infection.
3/18/20
Park S, Brassey J, Heneghan C, et al.  | Oxford COVID-19 Evidence Service
Aim: To review the evidence on managing fever in adults with possible or confirmed COVID-19 in primary care.
3/17/20
Aronson JK, Ferner RE, DeVito N, Heneghan C | Oxford COVID-19 Evidence Service
3/17/20
Ferner R | Oxford COVID-19 Evidence Service
3/16/20
Heneghan C, Brassey J | Oxford COVID-19 Evidence Service
Aim: To review the evidence using NSAIDs in patients with acute respiratory infection.
3/16/20
Heneghan C, Aronson J, Hobbs R, Mahtani K | Oxford COVID-19 Evidence Service
3/1/20
 | ECRI
Aim: To review the evidence on the effectiveness of antimicrobial copper surfaces in reducing health-associated infection risk.
3/1/20
 | Health Technology Wales
Aim: To review the evidence on digital applications for the diagnosis of actue respiratory disease.
2/6/20
Cupertino M, Rsende MB, Mayer NAJ, et al. | Asian Pacific Journal of Tropical Medicine
Aim: To review studies on the role of wild animals as reservoirs and/or dispersers of etiological agents of human infectious diseases in order to compile data on the main wild animals and etiological agents involved in zoonotic outbreaks
2/1/20
 | ECRI